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Platelet Adhesiveness: A possible link between the lipid and thrombogenic
theories of atheroma production.
SUMMARY
The main aim of the thesis is the investigation of the relationships 
between platelet adhesiveness and serum lipids in vivo. If it were possibl< 
to link these then the platelet would become a bridge between the lipid and 
thrombogenic theories of atheroma production.
Section I includes a review of the lipid and thrombogenic theories of 
atheroma production together with the abundant evidence from the literature 
linking platelets and lipids in vitro. Evidence that platelets are involvec 
in the formation of atheromatous plaques is also presented.
The lipids measured in the experimental sections of the thesis were plasr 
non-esterified fatty acids (NEFA),because these are known to affect platelet 
function in vitro, and serum cholesterol and serum triglyceride which are 
known to be elevated in subjects with ischaemic heart disease. . Blood sugar 
levels were also measured.
Platelet adhesiveness was used as the measure of platelet function becau£ 
it is known to be elevated in subjects with ischaemic heart disease and 
clearly if platelets are important in the development of atheroma, this 
measure is likely to be the relevant one. A further reason was that the 
effects of plasma NEFA on platelets in vitro appeared from the literature 
to be mediated by a mechanism involving adenosine diphosphate (ADP) on 
which platelet adhesiveness measured by the Payling Wright method also 
depended.
The various methods of measuring platelet adhesiveness are reviewed and 
the chosen method, a modification of that of Payling Wright, is described ir 
detail. The accuracy of the method was investigated and a brief study was 
conducted to determine the variation in platelet adhesiveness due to age, 
sex and the presence of ischaemic heart disease.
In Section II, studies of platelet adhesiveness following stimuli causing 
mobilisation of body fat are described. The stimuli used were adrenocortica 
stimulating hormone (ACTH) in rabbits and in man, surgery, cigarette smoking 
exercise, starvation, noradrenaline infusion and isoprenaline. The lipid an
platelet adhesiveness changes resulting from these stimuli are detailed 
and compared with the findings of other workers.
In Section XII, the effects on platelet adhesiveness of the oral, 
administration of substances known to affect lipid metabolism were 
investigated. These substances were fat, glucose, sucrose, l^ïinolenic acid, 
and clofibrate. The platelet adhesiveness and serum lipid changes resulting 
from the administration of these substances are described and the relevant 
literature reviewed.
Section IV includes a review of the thesis along with the conclusions 
from the experimental work carried out.
The main conclusions concerning platelet adhesiveness are:-
1) Measurement by the Payling Wright method is technically simple and 
is reasonably reproducible,
2) Variation in the interval between venepuncture and measurement of 
platelet adhesiveness affects the result. The longer this interval 
is, the greater the adhesiveness will be. For measurements to be
comparable this interval must be kept constant,
3) Variation in platelet adhesiveness from day to day is greater than 
that simply due to experimental errors,
4) Platelet adhesiveness is not influenced by the age or sex of the 
subject.
5) It is increased significantly in subjects with ischaemic heart 
disease.
6) It is not increased by the acute effects of cigarette smoking,
7) It is unaffected by sucrose in the diet.
8) It is not increased in obese subjects and is not affected by weight 
reduction,
9) It is increased by exercise.
- 10) It is increased by minor stress such as the embarrassment of smoking 
an unlit cigarette,
11) It is increased by major, stress in the form of a surgical operation,
12) It is increased by noradrenaline and Isoprenaline.
13) It is increased following the oral administration of fat.
14) It is also increased following' glucose given orally.
15) It is not altered by the oral administration of ^ linolenic acid.
16) It is not altered by clofibrate,
17) Platelet adhesiveness is not influenced directly by changes in 
plasma NEFA.
18) It is not affected directly by changes in serum cholesterol.
19) It is not affected directly by changes in serum triglyceride.
20) Changes in blood sugar do not directly affect platelet adhesiveness.
No relationship could be demonstrated in vivo between platelet adhesivene: 
and serum lipids. The lipid and thrombogenic theories of atheroma productioi 
could therefore not be linked via platelet adhesiveness. The significance 
of the increased platelet adhesiveness found in subjects with ischaemic 
heart disease in relation to the development of atheroma is doubtful because 
of this, and because factors predisposing to ischaemic heart disease (such 
as cigarette smoking, obesity and possibly dietary sucrose) are not associati 
with increased platelet adhesiveness while protective factors (exercise and 
clofibrate) are not associated with decreased adhesiveness.
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SECTION I
INTRODUCTION AND METHODOLOGY
chapter I
Introduction
In 1965, 23% of all deaths In Scotland were due to ischaemic heart 
disease (arteriosclerotic heart disease including coronary disease) 
and in the age group 50-55 years for men, this reached the high proportion 
of 41% (Annual Report of the Registrar General for Scotland, 1965).
The problem of ischaemic heart disease appears to be particularly acute 
in Scotland, which along with South Africa (European population), Finland 
and the U.S.A., has one of the highest levels in the world (Office of 
Health Economics, 1966). The cause of this crippling and lethal disease 
is unknown.
The basic lesion is atheroma. There are two main theories concerning 
the formation of atheromatous plaques. Firstly there is what is usually 
termed the "Thrombogenic theory", which is associated with the names of 
Rokitansky (1852) and Duguid (1946). This theory states that the 
origin of the plaque is the deposition of thrombus on the intima of the 
blood vessel. This subsequently becomes incorporated into the intima, 
eventually resulting in the atheromatous plaque. The other "lipid theory" 
suggested by Virchow in 1862 and supported by Aschoff (1933) states that 
disordered lipid metabolism is the primary abnormality. Lipid derived 
by phagocytosis, by filtration from the blood, or by local synthesis, 
becomes deposited in the intima thus setting up a focus of irritation which 
results in plaque formation.
There are several pieces of evidence in support of each theory. Spontaneous 
thrombosis appears to occur, at least in animals, on the aorta (Geissinger, 
Mustard and Rowsell, 1962) and these thrombi consist mainly of platelets. 
Similar thrombi in extracorporeal shunts have a distribution around 
bifurcations and branches strikingly similar to the distribution of 
atheromatous plaques. (Murphy, Rowsell, Downie, Robinson and Mustard,
1962). Thrombosis however might not be spontaneous and may be initiated
by trauma to the vessel wall due to turbulence created around bifurcations 
and branches. It is interesting that Gutstein, Laazarini-Robertson and 
La Taillade (1963) have shown that micro-trauma can result in the formation 
of an atheromatous plaque.
This experimental work in animals forms the basis of the thrombotic 
theory. In man, the evidence is less direct, although Duguid (1952) has 
shown that even large thrombi can become incorporated into the intima of 
vessels in man. Several indices of increased blood coagulability have 
been found in patients with ischaemic heart disease compared to controls. 
Thromboplastin generation, plasma fibrinogen and the Stypven clotting time 
fall into this category (McDonald & Edgill, 1957 & 1959). The most 
interesting abnormality however in the light of the animal experiments just 
quoted is increased platelet adhesiveness. This has been shown using 
different methods by McDonald & Edgill (1957) Owren, Hellem & Odegaard (1964), 
Nestel (1961) Besterman, Myat & Travadi (1967). Blood platelets could 
therefore be of central importance in the formation of the atheromatous 
plaque and in the accompanying thrombosis in ischaemic heart disease.
The problem of ischaemic heart disease is not directly related to the 
amount of atheroma however. For example in Jamaica (Robertson 1959) and 
Guatemala (Tejada & Gore 1957) atheroma is common while myocardial 
infarction is rare. Also Morris (1951) in a study of the necropsy records 
at the London Hospital found that although there had been a sevenfold 
increase in the number of cases of coronary heart disease, the amount of 
severe atheroma had in fact declined. If one accepts the idea that 
myocardial infarction is caused by coronary occlusion (and even this is 
disputed(Spain & Bradless I960)), then, since the amount of atheroma does 
not parallel the amount of myocardial infarction, two thrombotic tendencies 
must be involved if the thrombogenic theory is correct, - one resulting in 
the formation of atheroma, the other in thrombosis over the plaque. This 
division into two separate components weakens this theory. It is further 
weakened by the fact that it does not explain the accumulation of lipid in 
the plaque although it has been shown that platelet cholesterol and phospholipid
levels appear to parallel the blood levels (Murphy, Rowsell, Downie,
Robinson and Mustard 1962).
The lipid theory is supported by the presence of lipid in atheromatous 
plaques and by the ability of high cholesterol diets in rabbits to 
produce fatty deposits in the intima of large arteries. The presence of 
elevated blood lipids in patients who have had a myocardial infarction 
and also the increased incidence of myocardial infarction in those with 
elevated blood lipids - for example cholesterol (Dawber, Kannel, Revotskie 
and Kagan (1962) Morris, Kagan, Pattison, Gardner & Raffle (1966) strengthens 
this hypothesis. It has been said that the lipid theory does not account 
for thrombosis (Pickering 1964) but this is not entirely true since 
elevation of blood lipids by fat feeding can shorten the clotting time 
(Fullerton, Davie, Anastosopoulos 1953) increase platelet turnover (Mustard 
& Murphy 1962) and possibly inhibit fibrinolysis (Greig 1956, Gillman,
Naidoo & Hathorn 1957 Billimoria, Drysdale, James & MacLaggan 1959) 
although this is disputed (Hougie & Ayers 1960 Ogston & Fullerton 1962).
The lipid theory does not explain the distribution of plaques of atheroma 
within the arterial system however.
Whether the lipid or thrombogenic theory is accepted, the divergence of 
the incidence of myocardial infarction from the amount of atheroma suggests 
that at least two mechanisms are involved in the production of ischaemic 
heart disease. An alternative view would be that there are basically two 
types of atheromatous plaque, one which is essentially fibrous and the 
other consisting mainly of lipid which would in fact be an "atheromatous 
abscess". The latter type would tend to rupture and be complicated by 
thrombosis, while the fibrous plaque would be rather inert and be 
associated with a low incidence of ischaemic heart disease. This type of 
thinking still requires at least two independent processes producing the 
types of plaques at each end of the spectrum. Could the lipid and 
thrombogenic theories both be valid thus providing the two required 
independent processes? If this was the case then one would expect some 
common ground between them. The blood platelet which occupies a central 
position in the thrombogenic theory could be the point of focus between
5the two theories since there is abundant evidence in the literature linking 
platelets and lipids in vitro. This evidence will be reviewed later in 
Chapter 6. The important point to be noted at this stage is that if this 
link could be substantiated in vivo, the platelet would form a bridge 
between the thrombogenic and lipid theories. The purpose of this thesis 
is to investigate the possibility of a link between plasma lipids and 
platelet adhesiveness, both of which are known to be abnormal in ischaemic 
heart disease.
Chapter 2
History and Review of Methods of Measuring Platelet Adhesiveness
Helen Payling Wright in 1941 was the first person to measure platelet 
adhesiveness quantitatively. Prior to this in 1927, Rowntree and Shionoya 
had observed platelet adhesion to the walls of extracorporeal shunts. They 
had attempted to measure this function of platelets by recording the time 
taken for the shunt to be completely obstructed. This proved to be very 
variable the circulation ceasing in 6 to 10 minutes usually "or at most 
in very large and vigorous animals in 25 minutes"! Best,Cowan & McLean 
in 1938 improved this technique by transilluminating a glass cell built 
into the shunt and was able to record the growth and formation of white 
thrombi. Payling Wright's method however eliminated the variation due 
to size andvigour of the animal by carrying out the measurement of platelet 
adhesiveness completely in vitro. Blood was withdrawn, heparinised and 
within 5 minutes was placed in a glass flask which was rotated at 3% r.p.m. 
This blood was sampled at regular intervals. Platelet counts were carried 
out on all the samples and were expressed as a percentage of the original 
count. She was able to show that platelets were adhering to the side of 
the glass flask. Since the area of glass with which the blood had been 
in contact was fixed for each sample, the number of platelets lost from 
the blood could be taken as a measure of their adhesiveness. Comparisons 
could therefore be made between the platelet adhesiveness of different 
people and of the same person at different times. Using this method 
she showed that the amount and type of anticoagulant added to the blood 
affected the platelet adhesiveness. Later, in 1942, she showed that 
platelet adhesiveness increased post operatively and like the platelet 
count was highest at the 10th day post operatively. Platelet adhesiveness 
appears then almost to have been forgotten until 1957 when interest was 
reawakened by the finding of Macdonald & Edgill (1957) that it was elevated 
in patients with ischaemic heart disease. Since then numerous publications 
have appeared on many aspects of this subject and inevitably the number of 
ways of measuring platelet adhesiveness has multiplied. These are summarised 
in Table I.
Table I
Methods of measuring platelet adhesiveness
(a) In vitro
1. Adhesion of platelets to glass
(a) Payling Wright (1941)
(b) Hellem (1961)
(c) Salzraan (1963)
(d) Moolton & Vroman (1949)
(e) Caspary (1965 a)
2. Platelet to platelet adhesion
(a) Born & Cross (1963)
(b) Cunningham, McNicoI & Douglas (1965)
(c) Eastham (1964)
(d) Hutcheson, Stark & Chapman (1959)
3. Platelet to platelet adhesion and platelet to glass adhesion 
(a) Stormorken, Lund-Riise & Rorvik (1965)
(b) In vivo
Borchgrevink (1960)
7.
Several methods have been based on Payling Wright's in that they involve 
exposure of blood to a standard area of glass for a set time. Hellem's 
(1961) method involves the passage of citrated blood through a standard 
glass bead column. The time of contact between blood and glass is reduced 
to 23 sec. in this method compared to a minimum of 20 minutes using the 
Payling Wright method. This possible advantage is offset by the 
complexity of the apparatus required. The blood has to be pumped through 
the column at a standard rate and each column must be packed to the same 
density with glass beads of a standard size. A larger volume of blood 
is also required for this method. Hirsh, McBride & Wright (1966) have 
shoxm that there is a correlation between platelet adhesiveness measured 
by Hellem’s method and that measured by Payling Wright's. Both methods 
have been shown to depend mainly on the release of adenosine diphosphate 
(ADP) from red blood cells (Gaarder, Jonsen, Laland, Hellem & Owren 1961; 
Caspary 1965 (b); Harrison & Mitchell 1966). The methods appear therefore 
to be measuring similar functions of platelets and to give similar results 
in spite of the marked difference in the time during which the blood is in 
contact with the glass. Salzman's modification (1963) of Hellem's method, 
on the other hand, in which the glass bead column is attached directly to 
the venepuncturirig equipment and in which, therefore, platelet adhesiveness 
is measured prior to the addition of an anticoagulant, appears to measure 
a different platelet function. This is shown by the fact that when this 
method is made almost identical to that of Hellem's, by citration of the 
blood prior to its passage through the column, adhesiveness is abolished. 
(This apparent anomaly is explained by the increase in platelet 
adhesiveness with time after venepuncture (Hellem 1961) since the 
measurement is made by Salzman immediately after, compared to 15 minutes 
after venepuncture by Hellem). Moolton & Vroman (1949) passed blood 
through a glass wool filter but the surface area with which platelets are 
in contact is not standardised in this method. Caspary's method (1965 q.) 
involves the adhesion of platelets to a glass slide of standard size which 
is agitated in blood in a polythene container. None of these methods 
which basically involve contact with glass appear to have any advantage
over the original Payling Wright method.
8There are several methods of measuring platelet to platelet adhesion. 
The best of these is that described by Born & Cross (1963). In this 
method, the optical density of platelet rich plasma in a transparent 
plastic container is measured by passing a light through the container 
onto a photo electric cell connected to a galvanometer. The optical 
density is kept uniform using a magnetic stirrer covered with plastic.
This also causes the platelets to collide with one another. On addition 
of ADP or indeed any other agent causing platelet aggregation, the changes 
in optical density due to platelet clumping can be recorded against time, 
the greater the aggregation, the greater will be the increase in the 
transmission of light. This method has the advantage that the effects 
of various agents in differing concentrations can be compared. Platelet 
to platelet adhesiveness could therefore theoretically be determined by 
measuring the response to a standard amount of ADP. An objection to this 
is that some account would have to be taken of the initial platelet count 
in the platelet rich plasma. This could theoretically be overcome by 
expressing the change in optical density as a percentage of the difference 
in optical density between platelet rich and platelet poor plasma, since 
this correlates with the platelet count (Born & Cross 1963). Even when 
this is done however. Born and Cross have shown that the response to a 
standard dose of ADP diminishes with further centrifugation of platelets. 
This suggests that the more ADP sensitive or stickiest platelets tend to 
be preferentially centrifuged, an observation also made by Stormorken, 
Lund-R'iise & Rorvik (1965). This is a serious drawback which applies to 
all methods using platelet rich plasma. Changes in adhesiveness could 
be masked by variation in the number of platelets preferentially 
centrifuged.
Another measure of platelet to platelet adhesiveness is the time from 
addition of calcium to citrated or oxalated platelet rich plasma in a 
Chandler tube (1958) until the platelet snow storm appears prior to 
thrombus formation (Cunningham, McNicol & Douglas. 1965), Eastham (1964) 
measured platelet to platelet adhesiveness by adding ADP to heparinised 
blood in a polystyrene bottle which was rotated on a Matburn mixer for
30 minutes. EDTA was then added to stop aggregation and the platelet
9count was compared with another sample which had been placed in EDTA 
originally. Prior to the development of this method, Hutcheson, Stark,
& Chapman (1959) rotated platelet rich plasma at 33 r.p.m. on a turntable 
and measured platelet adhesiveness as the time taken for the platelet 
count to fall to 50% of the initial count. This unfortunately takes 
over 1 hour. These 3 methods basically measure platelet to platelet 
adhesiveness. Another method has been described by Stormorken, Lund-Rlise 
& Rorvik (1965) which appears to measure both platelet to platelet 
adhesiveness and platelet adhesiveness to gla&s. Platelet rich plasma 
after the addition of a standard amount of ADP solution is run through 
the standard glass bead column described by Hellem, The adhesiveness 
is expressed as described in Hellem's method. The object of this method 
is to eliminate the effect of packed cell volume which would be a 
variable when comparing adhesiveness between individuals. It is not 
clear however how this method compares with other methods. Certainly 
Rozenberg and Stormorken (1967) were unable to find any correlation between 
this method and Born & Cross's method measuring platelet to platelet 
adhesion only.
Borchgrevink in 1960 described a method of measuring platelet 
adhesiveness in vivo. A sphygmomanometer is inflated to 40 mm.Hg. on the 
upper arm and a cut 10mm x 1 mm deep made transversely on the volar 
surface of the forearm. The platelet count in the blood from the cut is 
used along with the count in venous blood to calculate the percentage of 
platelets adhering in the wound. This method would appear to suffer irom 
several drawbacks. Values from different people will not be comparable 
since the diameter of arms is very variable and the blood flow to the arm 
with the cut will be variable as a result of this and other factors such 
as environmental temperature. The method also assumes even distribution 
of platelets in the peripheral circulation which is known not to be the 
case. The major difficulty however would appear to be the standardisation 
of the size of the cut.
After consideration of all the above methods of measuring platelet 
adhesiveness, the Payling Wright method was chosen for the following
reasons :-
10
1) The equipment required is simple.
2) Measurement is simple
3) Only 2 ml., of blood are required.
4) The method is at least as good as other methods.
5) Platelet adhesiveness measured by this method is abnormal in subjects 
with ischaemic heart disease.
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Chapter 3
Method and accuracy of platelet counting and adhesiveness measurements
The measurement of platelet adhesiveness by the Payling Wright method 
depends on the counting of platelets.
Platelet counting
There are many methods of counting platelets. The first examined was 
that used in the Haematology Department of the Western Infirmary. This 
method involved diluting one volume of blood in 20 volumes of freshly 
filtered 1% ammonium oxalate and counting the platelets under light 
microscopy. The ammonium oxalate caused the red cells to haemolyse and 
this in turn made the counting of platelets very difficult because red­
cell remnants obscured the field. Also it was often difficult to 
distinguish between fragments of this debris, specks of dust and platelets 
A basic requirement for a satisfactory method of platelet counting is 
confidence that one is actually counting platelets. This method did 
not meet this requirement.
The difficulty resulting from the red cell debris could be eliminated 
using a method which did not lyse red-cells. One such is the Rees Ecker 
method (1923) which has the further advantage of using brilliant cresyl 
blue, which stains the platelets. This produced the necessary degree 
of confidence, but the presence of red cells meant that a dilution of 
1 in 100 was necessary in order that platelets were not missed when 
scanning the field. The dilution factor meant that several chambers 
had to be counted in order that sufficient platelets would be included.
Phase contrast microscopy was then tried. It was found to make 
little difference to the Rees Ecker method but when applied to the 
ammonium oxalate method, clearly overcame the difficulty of recognising 
platelets confidently. Platelets were easily identified by their bluish 
tinge, and this type of microscopy enabled one even to see pseudopodia 
extending from many of the platelets. The ammonium oxalate method using
12
phase contract microscopy was first described by Brecher & Cronkite in 
1950. This method was finally adopted because only a dilution of around 
1 in 20 was required and platelets could easily and confidently be 
identified and distinguished from dust and red cell debris.
Technique and Accuracy of Platelet Counting
All platelet counts were carried out on citrated blood. The technique 
of venepuncture and dilution of the blood with citrate will be described 
in the next section "Technique of Measuring Platelet Adhesiveness".
0,2 ml. of the citrated blood was diluted in 4 ml. freshly filtered 1% 
ammonium oxalate in a polystyrene container. In the case of the citrated 
blood, the pipette was washed outby sucking the diluting fluid in and out 
several times. The polystyrene container was then stoppered and the 
contents mixed gently. After several minutes, haemolysis of the red 
cells occured and the platelet count could thereafter be carried out. A 
sample of this solution was placed in a Neubauer chamber and the platelets 
were allowed to settle for about 15 minutes. Evaporation was prevented 
during this time by having the chamber in a Petri dish containing moist 
cotton wool. The platelets were then counted using phase contrast 
microscopy. The area which was counted was variable. At least one 
column (0.2 sq.mm) of the central square on each half of the chamber was 
counted. If the total number of platelets in this area was less than 400, 
then further 0.2 sq.iran columns were counted until the total number of 
platelets counted was greater than 400. The number of platelets in 1 Cu.mm, 
was then evaluated by multiplying by 1050 and dividing by the number of 
0.2 sq.mm. columns counted. The counts thus obtained were then corrected 
to the nearest 100. It should be emphasised that the counts quoted in 
this thesis are counts on citrated blood. 10% should be added to the 
quoted platelet count to obtain the count in whole blood.
The accuracy was checked by carrying out platelet counts on 2 occasions 
within 20 minutes on 31 subjects. The errors involved included the 
technique of venepuncture, dilution with anticoagulant, dilution with 
ammonium oxalate, and the error due to variation in the counting chambers.
Table II Duplicate platelet counts ( /c.tnm)
Estimate I j Estimate 2 Difference
209,000 193,600 15,400
154,600 155,400 800
188,400 180,400 8,000
208,000 218,000 10,000
242,800 208,800 34,000
259,200 265,200 6,000
257,400 228,600 28,800
165,200 167,000 1,800
131,500 134,500 3,000
165,000 173,500 8,500
168,600 167,800 800
177,000 169,400 7,600
190,000 199,000 9,000
136,000 134,000 2,000
218,700 217,000 1,700
109,200 112,000 2,800
121,800 118,600 3,200
186,000 193,000 7,000
129,300 124,300 5,000
158,000 143,400 14,600
167,500 165,500 2,000
113,500 104,000 9,500
161,000 153,000 8,000
179,000 181,000 2,000
219,000 196,000 23,000
160,500 133,000 27,500
261,600 238,000 23,600
144,000 142,200 1,800
138,800 143,800 5,000
149,000 148,200 800
100,400
4
100,600 200
Mean Difference 8,830
S.D. 9,270
13
The duplicate counts were counted at random among other platelet counts.
The checking therefore included all the variables and each count is
therefore a completely separate platelet count. The duplicate counts
are shown in Table II. The coefficient of variation^(V) was calculated
from the formula V = where S.D. = p)s. in which S.D,
M N
is the standard deviation of the mean of duplicate platelet counts, M, is 
the mean of all platelet counts, X is one of the duplicate counts, m is 
the mean of duplicate counts and N is the number of duplicate counts.
The coefficient of variation is 5.3%. This compares favourably with that 
found by Bennett (1967 b) of 5.7% and by Borchgrevink (1960) of 7.1%.
Both of these workers assessed the coefficient of variation using the 
above formula for duplicate counts and both were using Brecher & Cronkite's 
method. The figures therefore are directly comparable.
Technique of measuring platelet adhesiveness
As already stated the method chosen was basically that of Payling 
Wright. Several modifications were made. Blood was withdrawn by clean 
venepuncture from a forearm vein, using a Gillette no.l disposable needle 
and a polystyrene syringe. If the venepuncture was not clean or if air 
bubbled into the syringe, the syringe and needle were discarded and blood 
was withdrawn using fresh equipment from a different vein. A tourniquet 
was used to distend the vein but excessive stasis was avoided in view of 
the conflicting evidence of its effect on platelet adhesiveness (Sarajas 
& Myllyla 1964; Stormorken, Lund-Riise,Rorvik 1965). After the blood had 
been drawn into the syringe, the needle was removed and 4.5 ml. of blood 
were mixed with 0.5 ml. of 3.8% sodium citrate in a polystyrene container.
The blood and citrate were then gently mixed, 2 ml. of this mixture were then 
transferred at a fixed time after venepuncture using another polystyrene 
syringe into a 50 ml. spherical Quickfit glass flask of a standard diameter, 
This flask was rotated around its long axis for exactly 20 minutes at 
3% r.p.m. Platelet counts were then carried out on the blood in the 
polystyrene container (initial count) and in the glass flask (final count).
The difference between the counts gave the number of platelets which had
adhered to a standard area of glass in 20 minutes. This number expressed
Table III Duplicate measurement of platelet adhesiveness
Estimation I Estimation 2 Differences
between
duplicates
Differences
between
Estimates 1 & 2
15.9 14.7 1.2 - 1.2
20.7 21.9 1.2 + 1.2
28.1 24.1 4.0 - 4.0
19.5 22.4 2.9 2.9
21.6 24.8 3.2 + 3.2
18.6 20.8 2.2 + 2.2
23.8 13.8 10.0 -10.0
32.8 28.0 4.8 - 4.8
27.5 26.0 1.5 - 1.5
19.7 29.7 10.0 +10.0
27.3 28.1 0.8 + 0.8
20.3 27.2 6.9 + 6.9
16.3 22.1 5.8 + 5.8
49.9 48.0 1.9 - 1.9
49.7 56.2 6.5 + 6.5
55.4 53.4 2.0 - 2.0
47.0 50.1 3.1 + 3.1
46.1 42.2 3.9 - 3.9
25.1 17.7 7.4 - 7.4
41.8 42.6 0.8 + 0.8
36.7 32.7 4.0 - 4.0
40.0 47.0 7.0 + 7.0
47.2 43.7 3.5 - 3.5
35.1 33.7 1.4 — 1.4
38.8 51.0 12.2 +12.2
48.3 53.4 5.1 + 5.1
47.5 47.4 0.1 - 0.1
38.9 47.2 8.3 + 8.3
19.7 32.3 12,6 +12.6.
45.5 40.1 5.4 - 5.4
47.8 52.3 4.5 + 4.5
Mean Differences 4.65 + 1.4
S.D. 3.4 5. 6
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as a percentage of the count of the blood In the polystyrene container
(initial count) gave the platelet adhesiveness. Platelet adhesiveness
g initial count - final count -
therefore =   ^
Accuracy of Platelet adhesiveness measurement
The accuracy of measuring platelet adhesiveness was assessed in exactly
the same way as in the case of the platelet count i.e. by carrying out
31 duplicate determinations. The results of these are shown in Table III.
It can be seen that duplicates can vary considerably. The mean difference 
+ \ +(-S.D.) between duplicates was 4.65 - 3.4. This means that in order to 
be 95% certain that 2 measurements of platelet adhesiveness are different, 
there would have to be a difference of over 11%. Payling Wright did not 
assess the reproducibility of her method, but Millac (1967a) using a 
modification of the Payling Wright method similar to the present one, 
found the standard deviation of replicate determinations to be 4.4%.
This means‘that 95% of his results would be within a range of 17.6% (4 
times the standard deviation). Put another way, there were differences 
of at least 17.6% between some measurements of platelet adhesiveness on 
the same blood sample. Clearly the present results are better than this, 
since the greatest difference between duplicates was 12.6%.
The fact that fairly large differences between duplicates can occur, 
means that there is little point comparing two isolated platelet 
adhesiveness measurements. The investigations in this thesis, are 
designed mainly on the basis of repetition of the same experiment with 
analysis of the differences between platelet adhesiveness before and 
after a stimulus using Student's t test. For example, in the above 
experiment, it is clear there is no change in platelet adhesiveness 
between estimate 1 and estimate 2. This in a sense is a control 
experiment as nothing happened to the subjects between the two measurements.
-f.
The difference of +1.4 (- SEM of 1.0) between the means is statistically 
insignificant. This result is similar to that obtained by Bennett (1967b) 
who found that the difference in platelet adhesiveness before and after a
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drink of water (i.e. also a control type of experiment) was -1.8^2.1 
using Hellem's method.
This method of measuring platelet adhesiveness departs from the 
original description of the Payling Wright method in several ways.
1) Sodium citrate was used as an anticoagulant instead of heparin. When 
heparin was used platelet counting was difficult because platelet 
aggregation usually occurred. This was also the experience of Perkins 
Osborn and Gerbode (1958) who found that platelet aggregation could
be prevented by small amounts of citrate. When sodium citrate was 
used there was no problem with platelet aggregation and platelet 
counting was easy,
2) There was no window in the side of the glass flask. This was used 
by Payling Wright to show that platelets were adhering to the glass 
and is unnecessary for measuring for platelet adhesiveness.
3) The time elapsing between venepuncture and measurement of platelet 
adhesiveness was standardised. The effect of varying this interval, 
when measuring platelet adhesiveness by the Payling Wright method, 
was unknown. This was therefore, investigated (Fyfe and Hamilton, 
1967a) and will now be described.
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Chapter 4
Effect of Variation of the interval between Venepuncture and measurement of
platelet adhesiveness
Method
18 ml. of blood was withdrawn by clean venepuncture into a polystyrene 
syringe containing 2 ml. of 3,8% sodium citrate solution. The blood and 
citrate were gently mixed and transferred into a stoppered polystyrene tube. 
A stop-watch was started at the time of venepuncture, and platelet 
adhesiveness was measured, commencing 3, 5, 7 and 20 minutes after 
venepuncture in each of ten subjects and 5 and 20 minutes after venepuncture 
in a further twenty five subjects.
Results
The results for each of the ten subjects are shown in Table IV. The mean 
results with the standard errors of the means are shown in figure I.
PLATELET 
ADHESIVENESS %
40 -
30 -
20 -
10
J- JL
3 5 7 lO 15 20
TIME (MINS.) AFTER VENEPUNCTURE
Figure I. Average platelet adhesiveness (%)t S.E.M in ten subjects at 3, 
5 , 7, and 2o minutes after venepuncture.
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The values at 5, 7 and 20 minutes differed significantly from the 3 minute 
value (p ^ 0.05, <.0.01, <[,0.01 respectively). The mean values for platelet 
adhesiveness at 5 and 7 minutes did not differ significantly from each 
other, but both were significantly different from the 20 minute value 
(p <0.01 and p-<0.05 respectively). The initial platelet count was not 
significantly altered.
Table V shows the mean results for platelet adhesiveness measured at 
5 and 20 minutes after venepuncture in thirty five subjects, including the 
ten in Table IV. This larger series confirmed the increase in platelet 
adhesiveness with time after venepuncture and disclosed a significant 
correlation between platelet adhesiveness measured at 5 minutes and that 
measured at 20 minutes after venepuncture.
PLATELET ADHESIVENESS % 
20 MIN. AFTER VENEPUNCTURE
70 1
60 ’
60 •
40
20
40 50 603010 20
Figure 2.
Relationship between 
platelet adhesiveness 
measured five minutes 
after venepuncture with 
that measured 20 minutes 
after venepuncture in 
35 subjects. Results 
for subjects with 
ischaemic heart disease 
are circled.
PLATELET ADHESIVENESS %, 5 HIN. AFTER VENEPUNCTURE
Table IV Platelet adhesiveness at 3, 5, 7 and 20 minutes after venepuncture 
in 10 subjects.
Subject No.
Time after venepuncture (min.)
3 5 7 20
1 22.9 26.6 34.3 39.4
2 26. 6 29.0 32.3 52.6
3 27.0 32.2 44-0 34.5
4 18.8 26.9 22.3 41.8
5 17.2 26.3 35.9 32.7
6 25.5 32.5 48.6 61.3
7 21.9 36.7 31.9 49.9
8 25.4 43.4 31.6 55.3
9 40.9 44.4 42.3 43.7
10 33.9 35.4 35.2 37.6
Mean 26.0 33.3 35.8 44.9
-f'
- S.D. -7.0 -6.8 —7.6 -9,4
Table V Mean platelet adhesiveness in 35 subjects at 5 and 20 minutes 
after venepuncture.
Time after venepuncture (min.)
5 20
+
Platelet adhesiveness: mean - S.D.. 
t Test ... ... ... ... ... . 
Correlation coefficient...
30.7Ï 9.6 43.6^11.9
5.0435 p < 0.001
r=0.5891 P <  0.001
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Discuss ion
Hirsh et al. (1966) reported a correlation between platelet adhesiveness 
measured by the method of Payling Wright and that measured by the method of 
Hellem. It is not surprising therefore that both methods should reveal 
an increase in platelet adhesiveness with time after venepuncture. The 
magnitude of the change in this investigation was similar to that found by 
Hellem.
As originally described, Payling Wright's method should be carried out 
within 5 minutes of venepuncture. Many published reports refer to the 
modification of McDonald and Edgill (1957) of the Payling Wright method, 
but the time of measurement in that paper was not stated and presumably 
was also within 5 minutes of venepuncture. To assess the results of 
investigations of platelet adhesiveness the timing of the measurement 
after venepuncture, and whether this was rigidly controlled, should be 
known. Since it was found that platelet adhesiveness measured 5 minutes 
after venepuncture and that measured 20 minutes after venepuncture are 
correlated, the timing of the measurement seems relatively unimportant, 
provided that it is constant. Errors arising from timing are less 
likely if the measurement is carried out, not in the first 5 minutes when 
platelet adhesiveness appears to be increasing rapidly, but later when the 
rate of increase is slower. This reasoning led Hellem to measure platelet 
adhesiveness 15 minutes after venepuncture. The time between venepuncture 
and measurement of platelet adhesiveness was therefore controlled 
accurately in all experiments in this thesis.
It was suggested subsequently by Holdrinet, Ewals & Haanen (1967) that 
the increasing adhesiveness may have been due to platelet aggregation and 
that this might have been caused by release of ADP from platelets during 
standing. We did not agree with this however since no aggregation was 
observed and because aggregation would have tended to lower the initial 
platelet count thereby reducing not increasing platelet adhesiveness (Fyfe 
and Hamilton 1967 b). Harrison & Mitchell (1966) and also Caspary (1965 b) 
have shown that platelet adhesiveness as measured by the Payling Wright 
method is mainly dependent on ADP released from red cells, not platelets.
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It has been shovm by Holdrinet et al. and also by Constantine (1965) 
that platelets become more responsive to ADP with time following 
venepuncture. A more likely explanation of the phenomenon would be 
that it is due to increasing sensitivity of platelets to ADP combined 
with increasing release of ADP from red cells.
20
Chapter 5
Variation in Platelet Adhesiveness with age, sex and diagnosis
The 5 minute adhesiveness results for the 35 subjects in whom platelet 
adhesiveness was measured at 5 minutes and at 20 minutes after venepuncture 
(Table V; figure 2) were analysed with respect to age, sex and diagnosis. 
The subjects had been chosen completely at random. There were 18 males 
and 17 females and the average age of the group was 47.7.years. There 
were 9 subjects (8 males and 1 female) with clinical or ECO evidence of 
ischaemic heart disease, the other diagnoses being
asthma................. 5
normal ............ 4
duodenal ulcer.........3
hypothyroidism.........3
thyrotoxicos is.........2
rheumatoid arthritis...2
diabetes............... 2
hypertension.........
albuminuria..........
renal failure....... .
pneumothorax.........
vaso vagal attack....
Results
The average platelet adhesiveness for the whole group was 30.7% A 
graph showing platelet adhesiveness against the age of the subjects is 
shown in figure 3. There was no correlation between the two, the 
correlation coefficient (r) being 0.101.
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Figure 3. Graph of platelet adhesiveness against the age of each 
subject.
The mean platelet adhesiveness (- SD) for males was 31.4-8.4% and 
for females was 30.0^11.0%
The subjects with ischaemic heart disease had a higher mean platelet 
adhesiveness compared to the others (34.2-7.1% compared to 29.5-10.2).
This difference however, was not statistically significant. Platelet 
adhesiveness in subjects with ischaemic heart disease appeared to increase 
at the same rate as the 'controls' (see figure 2). This was confirmed 
arithmetically by dividing the 20 minute value by the 5 minute value for
each subject.
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Discussion
The method of measuring platelet adhesiveness is based on that of 
Payling Wright. Unfortunately, Payling Wright did not use citrate as 
anticoagulant and therefore one cannot compare the overall average of 
30.7% with any of her results. All methods of measuring platelet 
adhesiveness adjust the area of glass in contact with the blood in a 
given time, to give adhesiveness values of this order. The combination 
of area of glass and time of contact appeared therefore to be satisfactory.
There was no correlation between platelet adhesiveness and the age 
of the subject, agreeing with the findings of Hirsh and McBride (1965) 
and of Millac (1967 b). The former workers did not find any difference 
in platelet adhesiveness between males and females and this too has been 
confirmed in the present study.
The average platelet adhesiveness for the subjects with ischaemic 
heart disease was higher than the others. The difference was not 
statistically significant because there was considerable overlap between 
the groups and because the number of subjects was relatively small.
Other workers have found considerable overlap between the platelet 
adhesiveness of subjects with ischaemic heart disease and controls 
(McDonald & Edgill 1957 and 1959; Owren, Hellem & Odegaard 1964; Nestel 
1961 Besterman, Myat & Travadi 1967). The difference therefore requires 
fairly lar&e numbers to demonstrate it. One could certainly not diagnose 
ischaemic heart disease by measuring platelet adhesiveness. It can be 
seen from figure 2 that there is considerable overlap between the subjects 
with ischaemic heart disease and other subjects. If platelets are involved 
in the formation of atheroma and platelet adhesiveness has any relevance 
to the problem, then this could be due to subjects having extensive 
atheroma but no clinical evidence of it. If this were true, one might 
expect some increase in platelet adhesiveness with age, but this was 
not found. What ever the reason platelet adhesiveness is not a good 
discriminator of ischaemic heart disease but is generally agreed by the
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workers already named to be elevated in ischaemic heart disease.
Several groups of workers have denied that platelet adhesiveness is 
elevated in ischaemic heart disease. Using the Payling Wright method, 
Weiner, Zeltmacher, Reich & Shapiro (1948) found that the platelet 
adhesiveness in 5 subjects with arteriosclerotic heart disease was 
within normal limits. Clearly this denial is not well founded. It has 
to be contrasted with the significant difference demonstrated by McDonald 
& Edgill (1957) when comparing 48 subjects with ischaemic heart disease 
with 48 age and sex matched controls. Gooding & Enticknap (1967) using 
Hellem's method mention that they did not find increased adhesiveness in 
subjects with ischaemic heart disease. They have not yet presented the 
evidence for this however,. Eisen, Tyson, Michael & Baumann (1951) and 
Bobek & Cepelak (1958) both using the Moolten and Vroman glass wool 
filter method, have suggested that platelet adhesiveness is normal in 
ischaemic heart disease. These workers' requirements for abnormality 
have been values above the normal range. As already stated there is 
considerable overlap between normality and ischaemic heart disease in 
regard to platelet adhesiveness.
The subjects with ischaemic heart disease did not have a greater than 
normal increase in platelet adhesiveness with time after venepuncture.
This means that any increased adhesiveness demonstrated in vitro is 
likely to be present also in vivo. If the increase had been greater 
than normal then the in vitro adhesiveness could have been increased 
while the in vivo adhesiveness of platelets could have been normal.
One might suggest that packed cell volume differences could 
explain the differences in platelet adhesiveness between subjects with 
ischaemic heart disease and controls since as already mentioned ADP 
from red cells is the main factor influencing the measurement. There is 
no way of standardising the packed cell volume since some form of 
centrifugation would be required. This could result in delay prior to 
the measurement of adhesiveness being carried out and also the problem 
of preferential centrifugation of 'sticky' platelets would arise. McClure, 
Ingram, Stacey, Glass & Matchett (1966) corrected for packed cell volume
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by assuming that the regression is linear and that the regression co­
efficient of platelet adhesiveness on haematocrit was unity. They 
therefore standardised all platelet adhesiveness measurements to 
correspond to a haematocrit of 43%. If therefore platelet adhesiveness 
proved to be 40% in patient with a haematocrit of 53% then the platelet 
adhesiveness would be corrected by 10% to 30%. This on the admission 
of these authors is a gross over-simplification. In the present thesis, 
this problem was overcome by investigating alterations in adhesiveness 
under various conditions rather than the absolute values. Minor 
alterations of the haematocrit are unlikely to have any significant 
effect on platelet adhesiveness and therefore no correction was made.
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Chapter 6
Evidence linking platelets with blood lipids
1) Cholesterol
Macdonald & Edgill in 1957 showed that subjects with ischaemic heart 
disease had significant elevation of platelet adhesiveness compared to 
controls. They subsequently demonstrated that this elevation of platelet 
adhesiveness could be lowered by putting the subjects on a rice and fruit 
diet. (McDonald & Edgill 1958). This diet also lowered their serum 
cholesterol and this suggested that there might be a relationship between 
the two since both were lowered by the diet. Lowering of the serum 
cholesterol by another measure, clofibrate therapy, was also found to 
lower platelet adhesiveness (Symons, deToszeghi & Cook (1964); Carson, 
McDonald, Pickard, Pilkington, Davies & Love (1966) but recently this 
has been challenged by O'Brien & Heywood (1966). The fact that subjects 
with ischaemic heart disease have elevation both of their serum cholesterol 
and of platelet adhesiveness and that both can be lowered together by 
one measure is a basis of a possible association between the two.
2) Triglyceride
A similar argument can be used to link serum triglyceride with 
platelet adhesiveness since serum triglyceride levels have been shown 
to be elevated in subjects with ischaemic heart disease (Albrink, Meigs 
6e Man 1961) and they too can be lowered by clofibrate therapy (Oliver, 1963, 
Hillman,Zumoff, Kessler, Kara, Rubin & Rosenfeld 1963).
Philip and Payling Wright (1965) showed that l%-2 hours after a fatty 
meal platelet adhesiveness was increased compared to fasting values. They 
showed that the optical density of the plasma was also increased at this 
time and therefore suggested that the lipaemia may have been the factor 
responsible for the increase in platelet adhesiveness. They did not 
analyse this further, merely speculating that it could either have been 
the elevation of the serum triglyceride (which was being measured by the
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optical density method) or of non-esterified fatty acids which was 
responsible. Further investigation into this post-prandial elevation 
of platelet adhesiveness will be described later.
Serum triglyceride has been measured as part of the present 
investigations to determine whether there might be an association between 
serum triglyceride and platelet adhesiveness.
3) Non-esterifled fatty acids
The bulk of the evidence suggesting a relationship between platelets 
and lipids incriminates non-esterified fatty acids. This relationship 
will be discussed : nder the following headings
a) Relationship between fatty acids and vascular occlusion.
b) Fatty acids and the coagulation mechanism.
c) Effects of fatty acids on platelets in vitro.
d) The effect of albumin on the interaction between fatty acids and
platelets.
e) Effects of fatty acids on platelets in vivo in animals.
f) Evidence linking fatty acids and platelets in man.
g) Summary and conclusions,
h) Lines of research suggested by this evidence.
The formulae of the fatty acids mentioned subsequently in the text 
are shown in Table VI.
a) Relationships between fatty acids and vascular occlusion
Injections of long chain saturated fatty acids into dogs are capable
of producing widespread thrombosis and death (Connor, Hoak & Warner, 1963; 
Hoak, Connor, Eckstein & Warner, 1964). When injected into the artery 
of the wing of a bat they can produce thrombosis with marked vaso 
constriction while unsaturated fatty acids (oleic (18/1) and linoleic 
(18/3))acids do not have this effect (Soloff & Weidman 1963). These 
experiments were carried out with the sodium salts of the fatty acids
in aqueous suspending media, the fatty acids existing as colloidal particles
known as micelles. In vivo, non-esterified fatty acids are normally 
bound to albumin (Goodman 1958 a) and therefore these experiments are
Table VI Formulae of fatty acids and related substances mentioned in text
 ^22:0 belienic acid CH (CH ) GOOH 
20
20:0
18:0
arachidic acid 
stearic acid
CH (CH ) COOH 
d 2 18
CH (CH ) COOH 
^ 1 6
18:1 oleic CH (CH ) COOH 
7
11
CH (CHg) CH^.
G 18:1 ricinoleic acid CH CH^ CH(OH) (CH^) CH^ 
11
CH (CH ) COOH 
 ^ 7
G 18:1 elaidic acid CH (CH ) CH
J z 7
11
CH (CH ) COOH 
 ^1
C 18:2 linoleic acid CH (CH ) CH 
11
CH CH^ CH 
11
CH (CH ) COOH 
7
18:3 linolenic acid CH CH^ CH = CH CH^ CH^
11
CH CH CH = CH (CH ) COOH I Z 7
G 18:3 ï<linolenic acid CH CH^ CH = CH (CH^) CH^
4
11
CH CH CH = CH (CH ) COOH 
 ^ 4
16:0 palmitic acid CH (CH ) COOH 
14
Table VI (Continued) Formulae of fatty acids and related substances
mentioned in text.
^ 16:1 palmitoleic acid CH^(CH^) CH - CH (CH^) COOH
14:0 myristic acid CH (CH ) COOH 
12
12:0 lauric acid CH (CH ) COOH 
^10
Prostaglandin E ( CH (CH ) CH(OH)CH=CH-CH-CH-(CH ) COOH 
4 1 1 = 6  
CH(OH) 0 = 0  
\  /
™ 2
Clofibrate OH3
1
Cl<f ^O-C-COOCg H 
1
CH3
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unphyslological. The addition of albumin to the fatty acids prior 
to their infusion diminishes their effect (Hoak, Connor, Eckstein &
Warner 1964) but Hoak, Connor & Warner (1966) have found evidence of 
thrombosis following the injection of 5% albumin solution containing 
fatty acids in a concentration of 2,000 j^ \Eq./I. into rabbits while a 
control solution containing 200-400 J^Eq./l. fatty acid had no effect.
The level of 2,000 J^Eq./I,, they found could easily be exceeded in 
rabbits by mobilising fat by means of ACTH injections - a situation 
also complicated by thrombosis (Hoak, Poole & Robinson 1963). Histology 
of the thrombi resulting from fatty acid infusion showed that they were 
made up mainly of platelets (Hoak 1964) just as one would expect after 
thrombosis as distinct from clotting.
(b) Fatty acids and the coagulation mechanism
Fatty acids accelerate the coagulation mechanism. Poole (1955 a) found 
that sodium stearate, palmitate and oleate shortened the calcium clotting 
time while elaidate, linoleate and ricinoleate had no measurable effect. 
Sodium stearate also increased and shortened the time required for thrombin 
generation. Connor (1962) found that all saturated fatty acids accelerated 
thrombin formation in a Chandler tube while unsaturated fatty acids had 
no effect. The effect of saturated fatty acids increased with increasing 
chain length. Glass, Kaolin, Bentonite, which are known to activate 
Hageman factor, had an accelerating effect similar to the longest chain 
fatty acias (behenic (22/0) and arachidic (20/0)). The fatty acids did not 
accelerate thrombus formation of the blood of Peking ducks which are 
deficient in Hageman factor. For these reasons Connor believed that 
fatty acids activate Hageman factor. This was confirmed by experiments 
using Hageman factor deficient blood by Margolis (1962) and Didesheim & 
Mibashan (1963) but denied by Botti & Ratnoff (1963) who believed that 
they activated factor XI (P.T.A.),
(c) Effects of fatty acids on platelets in vitro
That fatty acids are able to aggregate platelets has been shown in
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vitro by several groups of workers using basically the Born method. 
Generally the ability to aggregate platelets appears to depend on the 
saturation and chain length of the fatty acid. Mahadevan, Singh &
Lundberg (1966) found that all saturated fatty acids were capable of 
inducing platelet aggregation and that the longer the chain, the 
greater was the aggregation produced. Of the unsaturated fatty acids 
tested, although in general they produced less aggregation, oleic acid 
was almost as potent as stearic acid. Linoleic and linolenic acids were 
ineffective, and linoleic acid appeared to protect platelets to some 
extent from the effect of behenic acid. Hoak, Warner & Connor (1967) 
however, found that stearic, oleic, linoleic and linolenic acids all 
produced platelet aggregation, stearic being the most potent. The 
aggregation produced by all the fatty acids appeared to be irreversible. 
The aggretating ability (of stearic acid) was markedly reduced in the 
plasma of the patient with Hageman factor deficiency. This could mean 
that the fatty acids were producing aggregation by Hageman factor 
activation. This was also suggested by Shore & Alpers (1963) who 
measured the effect of fatty acids on platelets by determining the amount 
of histamine released. Using this method they also found that the amount 
of histamine released depended on the chain length of the fatty acid.
The reason for their suggesting that Hageman factor activation may have 
been a factor, was that when the platelets were suspended in buffered 
bovine albumin and therefore were not in contact with coagulation factors, 
there was no measurable platelet damage. Another interpretation of this 
however would be that the albumin solution had bound the fatty acids 
thereby protecting the platelets from their effect. Kerr,Pirrie, MacAulay 
and Bronte-Stewart (1965) using fatty acid lethicin sols found that of the 
fatty acids they tested all aggregated platelets apart from linoleate and 
linolenate. Linolenate provided a protective effect against aggregation 
by other fatty acids. The effects, as found by others, were dependent 
on chain length and saturation of the fatty acid. Ardlie, Kinlough,
Glew & Schwartz (1966) using aqueous suspensions of fatty acids at 
concentrations much lower than used by other workers (approx, 1/lOth
of those of Kerr, Pirrie, MacAulay & Bronte-Stewart 1965) found that
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palmitic, stearic, oleic, linoleic and linolenic acids did not produce 
platelet aggregation but that stearic acid caused enhanced clumping of 
platelets by ADP. Haslam (1964),suggested that the aggregation of 
platelets by fatty acids is mediated via ADP. This was suggested on the 
basis that both adenosine and pyruvic kinase with phosphoenolpyruvate 
could prevent platelet aggregation by fatty acids since pyruvic kinase 
with phosphoenolpyruvate "mops up" ADP in a solution by forcing the 
following reaction to the right:-
h
phosphoenol pyruvate H- ADP + H pyruvate + ATP
pyruvate kinase
(d) The effect of albumin on the interaction between fatty acids and 
platelets
The obvious objection to all of these studies is that the fatty acids 
infused or used to aggregate the platelets were not in the "in vivo" state 
bound to albumin. Indeed incubation of stearic acid with albumin prior 
to its infusion into dogs prevented the expected thrombosis and death 
(Hoak, Connor, Eckstein & Warner 1964). In vitro platelet aggregation 
by fatty acids could also be markedly reduced by addition of albumin to the 
fatty acids (Hoak, Warner & Connor 1967). It would therefore appear that 
it is the binding of fatty acids to albumin which prevents disaster in the 
physiological situation. Goodman(1958 a) has investigated the binding of 
fatty acids to albumin. He found that there were 3 classes of binding 
site. The first class (tightest binding) consisted of 2 sites, the 
second of 5 and the third of approximately 20. Goodman (1958 b) 
subsequently showed that the second class binding sites on albumin had 
approximately the same association constant as binding sites on red blood 
cells. As red cell ghosts had a similar association constant he concluded 
that this binding of fatty acids to cell walls was independent of metabolic 
activity. He suggested that the avidity of cell membranes for fatty acids 
equal to that of second class albumin binding sites might be an important 
factor in explaining the very rapid transfer of fatty acids from blood to 
cells. If this is a generalised function of cell membranes then presumably
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platelets would be affected also. Assuming the plasma albumin 
concentration to be 40/100 ml., the molecular weight of albumin to be 
66,000 and the number of tight binding sites on each albumin molecule 
to be 2, then saturation of the tight binding sites would occur at a plasma 
fatty acid concentration of 121^Eq/l, If fatty acids have a significant 
in vivo effect on platelets one would expect them to have a dramatic 
effect above this plasma concentration since the second class albumin binding 
sites would be in equilibrium with binding sites on cell walls. If these 
sites are important in the rapid transfer of fatty acids, then one would also 
expect some effect on platelets below these levels if the turnover of fatty 
acids were to be increased. On theoretical grounds there is therefore 
plenty of in vitro evidence to suggest that fatty acids might have important 
effects on platelets in vivo. •
(e) Effects of fatty acids on platelets in vivo in animals 
Small doses of fatty acids given I.V. to rabbits have been shown to produce 
thrombocytopenia lasting for 1-2 hours (Zbinden 1964). The most active 
acids were found to be myristic & lauric; activity diminished with increasing 
and decreasing chain length, although behenic acid had activity similar to 
lauric acid. The effect of unsaturated acids linoleic and linolenic was 
comparable to that of palmitic while oleic was only active at very high 
concentrations. Zbinden thought his results might indicate a direct effect 
of fatty acids on platelets because the relative activity of the various 
acids was quite different from the in vitro results of Margolis (1962) 
who had sho\m Hageman factor activation. (Margolis had found that the 
long chain saturated acids were most active while lauric and myristic 
acids were almost inactive). A more important point suggesting that the 
fatty acids had produced platelet aggregation rather than thrombosis 
was the return of the platelet count to normal levels in 2 hours. 
Intravascular haemolysis probably occurred in some cases as several rabbits 
had haemoglobinuria. This raised the possibility that ADP released from 
red cells could have produced the thrombocytopenia but as haemoglobinuria 
occurred in the case of injection of acids which did not produce
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thrombocytopenia a direct effect on platelets would appear more likely,
(f) Evidence linking fatty acids and platelets in man
Turning to the evidence in man, it is interesting that thrombosis is 
said to be common in diabetics losing weight rapidly (Beckett & Lewis I960), 
Diabetics are known to have increased platelet adhesiveness (Bridges,Dalby,
Millar and Weaver 1965) and high plasma NEFÂ levels which would be expected to be 
be even higher during a period of fat mobilisation. It is therefore 
tempting to incriminate plasma NEFA in the increased incidence of thrombosis.
The elevation of platelet adhesiveness in ischaemic heart disease and in 
disseminated sclerosis - conditions in which fatty acid abnormalities have 
been claimed (James, Lovelock, Webb & Trotter, (1957), Baker, Thompson &
Zilkha (1964) is also in favour of a link between fatty acids and platelets.
It is interesting also that substances with a fatty-acid-like structure 
have been shown to affect platelet adhesiveness. Clofibrate, and 
prostaglandin E")whose formulae are shown in Table VI have a structural 
similarity to fatty acids and have been shown to affect platelets (Symons, 
de Toszeghi & Cook 1964;Carson,McDonald, Pickard, Pilkington, Davies and 
Love, 1963 and 1966; van Creveld and Pascha 1968). The ability of 
clofibrate to lower platelet adhesiveness has however been questioned 
(Millac, Caspary & Prineas, 1967 O'Brien & Heywood, 1966). Another 
interesting property of prostaglandin E| is its ability to inhibit the 
release of fatty acids from depot fat (Kupiecki, 1967; NaKawo, Ishii &
Gin, 1968). The effect of these substances on platelet adhesiveness 
therefore could involve a mechanism involving fatty acid metabolism.
When work for this thesis started a further piece of evidence favouring 
a link between fatty acids and platelet adhesiveness was the report by 
Owren, Hellem and Odegaard (1964) that linolenic acid was capable of 
reducing the elevated platelet adhesiveness found in ischaemic heart 
disease. This has since been denied by this group (Owren, Hellem &
Odegaard 1965) and by others (Borchegrevink, Berg, Shaga, Skjaeggestad 
& Stormorken 1965).
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(g) Summary and conclusions on relationship between fatty acids and platelets
The conclusion reached from all these studies would therefore appear to
be that saturated fatty acids are capable of producing platelet aggregation. 
This effect appears to increase with increasing chain length. The effect of 
unsaturated fatty acids is less clear. On balance, they would appear to 
aggregate platelets although their effect is much less than that of 
saturated fatty acids. Kerr, Pirrie, MacAulay & Bronte-Stewart (1965) and 
Mahadevan, Singh & Lundberg (1966) suggest that linolenic acid may protect 
platelets from the aggregating effect of other fatty acids. It is 
interesting that these observations on the effect of linolenic acid would 
have been in accord with the now retracted (Owren, Hellem & Odegaard, 1965) 
and disproved (Borchgrevink et al. 1965) work of Owren,Hellem & Odegaard, 
(1964) which showed that platelet adhesiveness to glass appeared to be 
reduced by the administration of linolenic acid orally to subjects with 
ischaemic heart disease. The protective effect of linolenic acid on 
platelet aggregation in vitro has also been denied however by Hoak,Warner 
& Connor (1967).Hageman factor appears to be involved in the acceleration 
of the coagulation mechanism and may be involved in platelet aggregation 
by fatty acids. ADP is involved and is probably"the final common pathway" 
in the production of platelet aggregation by various substances. The effect 
of fatty acids on platelets appears to be prevented by the binding of fatty 
acids to albumin but this binding mechanism may become saturated at plasma 
FFA levels which can be obtained in certain physiological and pathological 
conditions,
(h) Lines of research suggested by this evidence
The question to be answered therefore is do endogenous fatty acids have 
any effect on platelet function in vivo? Platelet adhesiveness has been 
used as the indicator of an effect on platelets because fatty acids appear 
to aggregate platelets via the ADP mechanism or if present in much smaller 
amounts make platelets more sensitive to the aggregating effect of ADP. It
has been suggested that fatty acids may cause a haeraolytic anaemic and 
therefore another possibility would be that the fatty acids could act on 
platelets via the red cells by releasing ADP from them. Platelet
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adhesiveness depends not only on the release of ADP from red cells but also 
on the sensitivity of platelets to ADP. If either of these mechanisms is 
in operation in vivo then one would expect to detect it by measuring 
platelet adhesiveness. A further reason for using platelet adhesiveness 
as the measure of platelet function is that it is known to be increased in 
subjects with ischaemic heart disease. If increased platelet adhesiveness 
is involved in the development of atheroma then this measure of platelet
function would be the relevant one,
In the following experimental section of this thesis various stimuli 
have been used to mobilise endogenous fatty acids and the effect of this 
on platelet adhesiveness has been studied. In Section III, the effects
on platelet adhesiveness of oral administration of substances known to
affect fat metabolism have also been studied.
SECTION II
STUDIES OF PLATELET ADHESIVENESS FOLLOWING 
STIMULI CAUSING MOBILISATION OF BODY FAT.
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Mobilisation of fatty acids in rabbits using adrenocortical stimulating 
hormone (ACTH)
Fatty acid infusions, as explained already, were thoughr to be unstable 
and completely unphysiological and were therefore not employed in this 
investigation. The first approach to the problem of the relationship 
between platelet adhesiveness and fatty acids was to induce fatty acid 
mobilisation by ACTH in rabbits in an experiment similar to that described 
by Hoak, Poole & Robinson (1963). These workers found that thrombosis 
and death was the usual outcome when large doses of ACTH (50 units/Kg.) 
were injected producing a five-to-seven-fold rise in plasma NEFA. They 
noticed a fall in the platelet count in 2 out of 5 rabbits 2 hours after 
ACTH but did not investigate this further. A similar experiment was 
designed for the present investigation.
Method and Results
Twelve rabbits were investigated. Basal blood samples were obtained 
by arterial puncture from the main artery supplying the ear. The rabbits 
were then given porcine ACTH subcutaneously. Four were given 50 units 
AGTH/Kg. and a further arterial sample was obtained after 2 hours. Four 
were given 25 units ACTH/Kg., the other 4 were given 10 units ACTH/Kg., 
and the post-ACTH specimens of blood were obtained after 1 hour in these 
two groups. The lower doses of ACTH were used in an attempt to reduce 
the mortality and to avoid in vivo platelet aggregation. The platelet 
count, platelet adhesiveness, packed cell volume, plasma NEFA and blood 
sugar were measured in all blood samples. Packed cell volume was measured 
using a Wintrobe tube after centrifuging at 3,000 r.p.m. for 30 minutes 
in a swing out centrifuge of 15. c.m. radius; Plasma NEFA by the method 
of Dole & Meinerts (I960) using Nile Blue as an indicator, the fatty acids 
being titrated with sodium hydroxide against palmitic acid standards in 
heptane; blood sugar using a Technicon Autoanalyser (Method N-2h) which
measures total reducing substances.
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In the high-dosage group, 2 of the 4 rabbits died within 24 hours and 
one of the others was killed. In the 25 units/Kg. group, one rabbit 
died. There were no deaths in the low-dosage group. Post-mortem 
examinations were carried out but failed to show any cause for the deaths, 
In particular, there was no evidence of thrombosis.
The results of the measurements made on the blood samples are shown in 
Table VII .
ACTH experiments 
Table VII
Mean Values - S.D
P value
Pre ACTH Post ACTH
platelet count 
X lO^/cmm
319 i 59.1 214 - 79.5 < 0.001
platelet adhesiveness
7o
24.8 - 12.9 31.4 t 9.2 N.S.
Non Adhesive
Platelet Count 
lO^/cmm
235.3 t 51.9 141.0 t 43.3 <(0.001
P.C.V. cy/o 35.5 t 3.5
33.8 t 3.6 < 0.01
plasma
166 t 82 1139 - 274 0.001
Blood glucose 
mg/100 ml.
68.3 t 23.1 93.1 t 29.7 ( 0.01
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The platelet count fell in all cases. The PCV also fell in all but 
2. The fall in the platelet count was greater than could be accounted 
for by the fall in the PCV and there was no correlation between the two.
It was thought that the drop in the platelet count indicated intravascular
aggregation of the platelets. One of the rabbits had an ear chamber and
this allowed microscopy of the capillary circulation. After ACTH, 
platelet aggregates were seen within the circulation of this rabbit.
Because of the fall in the platelet count after ACTH, the platelet 
adhesiveness estimations are not immediately relevant to the present 
studies, since if platelet adhesiveness is of any significance at all, 
the most 'sticky’ platelets would be expected to aggregate first. This 
difficulty can be overcome by comparing the non-adhesive platelet counts 
before and after ACTH. It can be seen that there was a highly significant 
fall in the number of non-adhesive platelets, suggesting a true increase 
in platelet adhesiveness.
ACTH produced a dramatic rise in the plasma NEPA levels together with
an increase in the blood glucose. The percentage changes in the NEFA and
blood glucose correlated well (r= 0,716;p<C0.01). The percentage change in 
NEFA was significantly less after 10 units ACTH/Kg. than that after 25 
units/Kg. The changes after 50 units/Kg. and after 25 units/Kg. were 
similar, probably due to the different timing of the post ACTH samples.
The percentage changes in blood glucose and plasma NEFA did not 
correlate with the percentage changes in platelet count or non-adhesive 
platelet count.
ACTH also produced a change in the appearance of the red cells. There 
appeared to be spicules around the red cell membrane, similar to 
’’acanthocytosis” in man. This change was seen when counting the platelets 
in the Neubauer chamber using Rees Ecker diluting fluid. The red cells in 
the pre-ACTH specimen were always normal.
Since the changes in platelet adhesiveness were being masked by platelet 
aggregation in spite of reduction in the dose of ACTH, it was decided to 
try to prevent platelet aggregation using heparin and carry out the same 
experiment.
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Effect of ACTH on platelets in the present of heparin
Six rabbits were investigated, A basal blood sample was withdrawn by 
arterial puncture from the main artery supplying the ear and following 
this, 500 units of heparin were injected intra-arterially. Each rabbit 
was then given 10 units ACTH/lCg. subcutaneously and a further arterial 
blood sample was obtained 1 hour later.
The results are shown in Table VIII. These results were compared with 
a control group which was treated in exactly the same manner except that 
no heparin was given. This group consisted of 7 rabbits, 4 of which had 
been included in the previous investigation in the 10 units ACTH/Kg. group.
It can be seen that heparin failed to prevent the drop in the platelet 
count following ACTH although this appeared to be less than in the non­
heparin group (Table IX). The average percentage change in the heparin
+ + 
group was 11.05 - 9.9 compared to 22.1 - 20,4 in the non heparin group.
However, this difference was not statistically significant. The fall in
the non-adhesive platelet count was also greater in the control group but
this difference also was not statistically significant.
Discussion
ACTH was shown by Di Girolamo, Rudman, Reid and Seidman (1961) to be 
capable of producing a tenfold rise in plasma NEFA in rabbits. The 
sevenfold rise found in the present series of experiments is of the same 
order and also similar to that found by Hoak, Poole and Robinson (1963). 
The in vitro work of White and Engel (1958) suggests that ACTH produces 
fatty acid mobilisation by acting directly on adipose tissue. The 
active principle may not in fact be ACTH but ’lipotropin' (Li, 1964) which 
is usually extracted along with it. The correlation between the change 
in blood sugar and the change in plasma NEFA suggests that the stimulus to 
both may be the same. Since adrenaline can produce both a rise in plasma 
NEFA and in blood sugar and since the rabbits were outwardly obviously 
in a stressed state as a result of the injection, adrenaline release may 
have been involved in the metabolic changes. ACTH is not thought to 
affect platelet adhesiveness (Millac 1967 c) but adrenaline is thought to
Mean values ± S.D.
Pre ACTH Post ACTH
platelet count heparin 383.4 - 123.3 
339.9 t 72.0
334.2 t 88.0
257.3 t 56.7
<  0.05
X 10^/ cmn\ control <0.05
Non adhesive heparin 261.I t 138.3 
248.6 - 19.6
198.0 t 125.3 
172.4 - 27.5
<0.05
platelet count control <0.05
PCV % hepar in 
control
36.4 j 3.5 
37.1 - 1.8
34.4 J 4.0
36.4 - 1.3
-
Table VIII Results of 10 units/Kg, ACTH subcutaneously in 6 rabbits given 
heparin intra-arterially compared to those in 7 rabbits which 
did not receive heparin.
heparin control
percentage 1.9 - 1.1
fall 2.4 5.3
in 3.6 6.1
platelet 13.9 24,0
count 19.4 25.1
for
25.1 34.6each
rabbit 58.8
Mean ll.li'9.9 22.1^20.4
Table IX The percentage change in platelet count following 10
units ACTH/Kg for each rabbit in the heparin and control 
groups.
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increase platelet adhesiveness (Besterman, Myat & Travadi 1967) and be 
capable of inducing platelet aggregation (O’Brien 1963).
There was no correlation between the changes in plasma NEFA and the 
changes in platelet count or adhesiveness nor between their absolute 
values. The platelet aggregation which occurred appears to have been a 
temporary phenomenon accompanying the rise in plasma NEFA. The animals 
which died, did so at the time when the lipaemia resulting from ACTH would 
have been expected (12-24 hours)(Kellner, Hirsh & Freeman, 1960) and when 
fatty acids were likely to have reached basal levels again. There was no 
evidence of thrombosis in any of these animals and therefore it is likely 
that the platelet aggregation had not proceeded to thrombosis. The fact 
that the aggregation was reversible is suggested also by the finding that 
in 3 of the rabbits (the others were not tested), the platelet count had 
returned to the pretreatment level by the next day.
The changes in the red cells similar to that seen in "acanthocytosis” 
in man are of interest. In that condition, red cells have been shown to 
be mechanically more fragile than normal (Singer, Fisher & Perlstein 1952). 
The fall in the packed cell volume is probably a manifestation of this.
This raises the possibility that the platelet aggregation may have been 
secondary to red cell damage leading to release of ADP. This change in 
the red cells was also temporary, and had resolved on the following day 
in the 3 rabbits. In "acanthocytosis", it has been shown that the defect 
is within the red cell and is not a function of the surrounding plasma 
(Salt, Wolff, Lloyd, Fosbrooke, -Cameron & Hubble 1960), Clearly therefore 
the changes noted following ACTH are not the same, although morphologically 
similar. Nevertheless, the fact that there are lipid abnormalities in 
"acanthocytosis" - abeta lipoproteinaeraia, low serum cholesterol,increased 
lysolethicin in the red cell and central nervous system disease (Salt et 
al. 1960) raises the possibility that the acute mobilisation of the fat 
following ACTH may have produced a similar effect on the red cell.
Heparin was given in a dose of approximately 150 units/Kg. which is 
a dose normally given therapeutically in man. At this dose level although 
there was some reduction in the amount of platelet aggregation it still
occurred.
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Heparin given in much higher doses (over 300 units/Kg,) inhibits platelet 
aggregation (Best,Cowan,& McLean, 1938, Solandt & Best 1940, Mustard, 
Murphy, Rowsell & Downie 1962). In the dose range applied here platelet 
aggregation is not prevented but the conditions producing it in all the 
experiments quoted have been extreme. The practical application of the 
present result is therefore not clear cut but it suggested that if platelet 
aggregation is to be prevented the dose of heparin used should be far 
higher than that usually used, probably of the order of 20,000 units in a 
70Kg.man.
Conclusion
Platelet aggregation occurs following ACTH in rabbits, associated with 
very high plasma NEFA levels. No direct correlation has been demonstrated 
between the plasma NEFA changes and platelet adhesiveness but further 
investigation is indicated in view of the evidence associating NEFA and 
platelets. The platelet aggregation may have been due to other factors 
such as adrenaline, or to ACTH itself, and may have been produced via 
the red blood cells.
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Chapter 8
Platelet Adhesiveness in the Immediate Post"Operative Period
In 1942 Payling Wright showed that there was an increase in platelet 
adhesiveness post operatively which was maximal along with the platelet 
count at about the 10th day. To explain this it was assumed that younger 
platelets were stickier than older platelets. The post-operative period 
in man is a stressful situation and Naftalin (1962) had demonstrated that 
there is elevation of plasma NEFA in the immediate post-operative period.
If there is any relationship between plasma NEFA and platelet adhesiveness
then one would expect elevation of platelet adhesiveness in the first
/
post operative day.
Ten subjects were investigated on the first day after operation. There 
were 5 males and 5 females. The average age of the group was 50 years.
The operations were as follows;-
gastro-enterostomy. ......4
cholecystectomy............   3
partial thyroidectomy.......... 1
resection of terminal ileum,...1
simple mastectomy..........   1
Blood was withdrawn pre-operatively from each at 9 a.m. The operation 
in all cases took place during the morning but the exact timing was variable, 
Following the operation at 2.p.m., 5 p.m. and 9 a.m. the next day further 
blood samples were taken. Only subjects who did not have post operative 
intravenous medication were used. Platelet count, platelet adhesiveness, 
plasma NEFA and blood sugar were estimated on each sample.
The controls consisted of a group of 7 males undergoing cystoscopy and 
who virtually therefore just had an anaesthetic and no significant tissue 
damage. These subjects were fasted until after the 5.p.m. blood sample 
had been withdraw. The experiment was terminated in the group at this stage 
The average age of this group was 55 years.
The results on the operated group are showi in Table X and for the 
anaesthetic group in Table XI.
Initial platelet count 
X lO^ /cmïvx
Platelet stickiness % 
/\Eq/l.
plasma
NEFA
blood sugar
mg/100 m/.
9 a.m.
+
188.9 : 51.4
38.0 t 9.5
534
4"
329
80.8 - 7.5
2 p.m.
199.2 - 37.7
*
48.1 t 12.1 
1050 t 532
■ïVvV
113. li 25.2
5 p.m. 
200.3 t 49.0 
45,3 - 19.7
887 t 300
,+
9 a.m.
4-
187.1 : 48.1
52.3 - 19.0
582 t 250
+
117.6- 30.3 107.9 - 13.9
Differences from
pre-operative values: p <0.05
p <0.02 
p <0.01
Table X Mean results (- S.D.) for the 10 subjects undergoing major surgery 
between 9 a.m. and 2 p.m.
9 a.m. 2 p.m. 5 p.m.
Initial platelet count
X 10^/cmh\ 149.9 - 27.3 149.9 - 25.6 147.4 i 25.1
Platelet adhesiveness ^ 42.4 t 9.3 43.9 t 8.0 45.3 - 8.7
plasma
^F,q/l.
585 - 93 588 i 82 645 t 196
blood sugar
mg/ 100 ml.
74 - 3.9 70 ± 6.1 75 -- 15.3
Table XI Mean results (- S.D.) for 7 subjects who had a cystoscopy between 
9 a.m. and 2 p.m.
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In the operated group the platelet count tended to rise slightly but this 
was not significant. The control group did not show any alteration in the 
platelet count. Platelet adhesiveness rose following surgery in all cases.
•At 2 p.m. 8 out of the 10 subjects showed an increase and this was statistically 
significant. At 5 p.m. platelet adhesiveness was increased in 7 out of the 
10 instances while at 9.a.m. the next day, 7 out of 9 showed an increase.
The mean adhesiveness at 5 p.m. and 9 a.m. was not significantly greater than 
the pre-operative value however. There was very much less variation in 
platelet adhesiveness in each individual who had only cystoscopy. The 
averages for this group were fairly close to one another although it is 
interesting that there was a tendency for platelet adhesiveness to rise as
the day went on. The blood samples at 9 a.m. the next day were not taken in
the control group as this would have necessitated continuing their fast until 
that time.
Plasma NEFA showed more uniform trends. The operated group showed a 
highly significant rise at 2 p.m. and 5 p.m, the highest levels being at 
2 p.m. By 9 a.m. the next day the levels were not significantly above the 
original pre-operative level. In contrast, the subjects who had only a 
cystoscopy did not show any significant changes in the plasma NEFA levels.
Blood sugar was significantly elevated in the operated group at 2 p.m.
and 5 p.m. This significant elevation was still present at 9 a.m. the next
day. The control group did not show any significant alteration in blood
sugar at any of the times tested.
Discussion
The maximal increase in plasma NEFA at 2 p.m. coincided with a significant 
elevation in platelet adhesiveness. There was no significant correlation 
between the changes however. The non significant increases in platelet 
adhesiveness found at 5 p.m. and 9.a.m. the next day also were not associated
with corresponding plasma NEFA changes. It would appear from the results
that the stimulus causing increased platelet adhesiveness was likely to have 
been maximal in the immediate post operative period. Bennett (1967 a) also 
found increased platelet adhesiveness immediately after operation. He
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attributed this to stress on the basis of the accompanying changes in the 
white cell count. This increase in platelet adhesiveness may have more 
relevance to the problem of deep vein thrombosis and pulmonary embolism 
than the later one demonstrated by Payling Wright, It is becoming 
increasingly clear that, although the maximum incidence of thrombo embolic 
episodes is around the 10th post operative day, the primary thrombosis occurs 
very much earlier.
Using accurate and sensitive methods, deep venous thrombosis can be 
detected in the early post operative period (1-3 days). Atkins & Hawkins 
(1965) using 1125 labelled fibrinogen, have been able to detect cases at 
this time. While the later increase in platelet adhesiveness demonstrated 
by Payling Wright may simply be in fact a function of new young platelets 
coming into the circulation, the increase in the first post operative day 
may be more significant and be the initiating thrombotic factor.
Increase in plasma NEFA post-operatively has been demonstrated previously 
by Naftalin (1962). The changes were not uniform in his cases but in the 
present series the pattern for each individual was similar. Peak levels 
were reached at 2 p.m. in 5 and at 5 p.m. in 5 cases. The 9 a.m. values 
the next day were only slightly above the baseline. Thus the stimulus 
to fatty acid mobilisation appears to have been maximal in the immediate 
post operative period (2 p.m.), the effect having declined by the next 
morning. The effect on glucose on the other hand was still continuing 
on the next day (9 a.m.). This is in accordance with the work of Ross,Johnston 
Welborn & Wright (1966) who showed high fasting blood sugars associated with insuli 
antagonism up to 72 hours post operatively. They speculated that fatty acids 
might have been responsible for the insulin antagonism but this obviously 
cannot be so since plasma NEFA levels have returned to normal within 24 
hours. These workers demonstrated increased levels of hydrocortisone and 
growth hormone - both insulin antagonists. From their data neither of 
these substances looked likely contenders in causing the insulin antagonism 
however. Increase in catecholamine secretion could explain the fatty acid 
changes particularly as they were maximal immediately after the operation.
This could also explain the initial elevation of the blood sugar but not its
persistence when the plasma NEFA levels had returned to normal on the
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following day. The possibility that the elevation of the blood sugar at [
I
9 a.m. on the day following surgery could be due to carbohydrate ingestion I
I
must be considered. The uniformity of the changes throughout the series |
I
of patients makes this unlikely as does the fact that Ross et al. also |
|:
demonstrated it. Thiopentone anaesthesia can cause insulin antagonism j
(Henneman & Bunker 1961) but this is not the explanation in the present !
investigation as there was no elevation of the blood sugar levels in the I
control group of patients.
Conclusions
Platelet adhesiveness was elevated in the first post operative day 
associated with elevation of the plasma NEFA levels. There was no direct 
correlation between the two. The elevation of plasma NEFA and of blood 
sugar immediately after surgery is thought most likely to have been a 
stress effect and the result of adrenal stimulation. The persistence 
of the elevation of the blood sugar was thought to represent insulin 
resistance but the reason for this could not be explained.
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Effects of cigarette smoking
The expectation of finding elevation of platelet adhesiveness in the 
first post operative day, based on the knowledge that plasma NEFA levels 
were elevated at this time, was fulfilled. Cigarette smoking is also 
known to elevate plasma NEFA levels (Kershbaum, Bellet, Dickstein &
Feinberg 1961) and is thought to elevate platelet adhesiveness (Ashby, Dalby 
& Millar, 1965). In view of the reported importance of cigarette smoking 
predisposing to ischaemic heart disease (Brit.Med.J. 1966) the effects of 
cigarette smoking both on platelet adhesiveness and serum lipids were 
considered to be of great interest.
Method
Twelve patients (8 males and 4 females) from a general medical ward 
who habitually smoked 10 or more cigarettes daily were investigated. They 
were aged 37-67 years with a mean age of 55 years. Their diagnoses were:-
ischaemic heart disease...... 3
peripheral vascular disease...3
hypertension.................. 1
idiopathic diarrhoea......... 1
simple goitre.................1
rheumatic heart disease...... 1
epilepsy...................... 1
pneumonia..................... 1
The patients fasted overnight and remained at rest in bed throughout the 
experiment. Two basal venous blood samples were taken 20 minutes apart.
The patients were then instructed either to smoke two of their usual brand 
of cigarettes during a 15 minute period or to sham smoking b)f puffing the 
unlit cigarette for the same length of time. A third blood sample was 
taken at the end of the 15 minute period, and three further samples at 10 
minute intervals. Within the next few days the experiment was repeated
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with sham smoking substituted for the smoking or vice versa. 7 patients 
smoked in the first experiment and 5 in the second. For determination of 
the individual non-esterified fatty acids the NEFA fraction was separated 
by thin layer chromatography using plates coated with "adsorbosil" 
impregnated with rhodamine B. The solvent system used with hexane/diethyl 
ether/methanol/acetic acid in a proportion of 90;20;3;2 V/V. The NEFA band 
was scraped from the plate and the fatty acids were eluted with ether and 
methylated with methanol and sulphuric acid. The fatty acids were separated
by gas liquid chromatography on a panchromatograph column containing 15%
polyethylene glycol adipate on Gas Chrom.P, Serum cholesterol was measured 
by a modification of the Technicon Autoanalyser Method N24P which basically 
involves a colour reaction between cholesterol, ferric chloride and sulphuric 
acid originally described by Zak, Dickenman, White, Burnett & Cherney (1954). 
Serum triglyceride was measured by the method of van Handel & Zilversmit 
(1957) which uses triolein standards.
Results
The results of the 12 smoking tests are shown in Table XII and those 
of the 12 sham smoking tests in Table XIII.
There was a significant rise in the mean plasma NEFA level after smoking,
reaching a maximum 10 minutes after the end of the smoking period and falling 
again to the basal level over the succeeding 20 minutes. While the plasma 
NEFA level increased to a variable extent in every case after smoking, after 
sham smoking the plasma NEFA level rose in 5 cases, was unchanged in 3 and 
fell in 4. The small increase after sham smoking was not statistically 
significant.
Both smoking and sham smoking were followed by a significant increase in 
the concentration of oleic acid in the NEFA fraction, and a significant fall 
in the concentration of palmitic acid. This effect was more notable after 
sham smoking than after smoking and did not correlate well with the changes 
in total plasma NEFA. The other fatty acids in the NEFA fraction showed a 
similar tendency for an increase in unsaturated at the expense of saturated 
fatty acids, but the individual changes were not significant.
There was no significant change in serum cholesterol or triglyceride levels
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in either group.
Smoking was followed by a small but significant increase in blood 
glucose. This happened in every case and showed no tendency to return to 
the fasting level. There was no change after sham smoking.
There was a significant transient rise in the total platelet count 
after smoking, but no change after sham smoking. On the other hand, there 
was a mean rise in platelet adhesiveness in both smoking and sham smoking 
groups. There was an increase in 9 of the 12 sham smoking tests, and 
in this group the mean rise was significant. The changes after smoking 
were more variable, a rise in 7 cases and a fall in 5 cases, and the mean 
rise was not statistically significant.
There was no significant difference between the 6 patients with arterial 
disease and the others, in basal serum lipid levels, blood glucose and 
platelet adhesiveness or in the magnitude of the responses to smoking.
There was no correlation between basal platelet adhesiveness and basal 
levels of either glucose or NEFA.
In the sham smoking group it was evident that there was a good correlation 
between the percentage rise in NEFA and the rise in platelet adhesiveness 
as shown in Fig. 4. % rise = 45 minute level ~ Mean basal level
Mean basal level
X 100
100-1
PLATEIÆT 
ADHESIVENESS 
(% CHANGE)
80-
60”
40-
20"
lOO60 80402020
20-
4CH
Figure 4.
Correlation between 
percentage changes in 
plasma NEFA and platelet 
adhesiveness after sham 
smoking.
y=0.51x + 9.19 (r=0.7091)
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This correlation was significant at the 1% level (r=0.709). There was 
a similar but less significant correlation between percentage changes in 
NEFA and platelet adhesiveness after smoking (r=0.584, p <^0.05) as shownin 
Fig .^5.
100 1
PLATELET 
ADHESIVENESS 
(% CHANGE)
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20 40 6020 80 loo
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PLASMA N.E.P.A. (% CHANGE)
Figure 5. Correlation between percentage changes in plasma 
NEFA and platelet adhesiveness after smoking.
y = 0.86x - 8.22 (r=0.5838)
In the smoking group however, there was a rise in glucose and Fig 6. 
illustrates the negative correlation between changes in blood glucose 
and platelet adhesiveness (r==0.701, p-^0.02).
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Figure 6. Correlation between percentage changes in blood glucose 
and platelet adhesiveness after smoking.
y=-3.6X+ 46 (r = -0.7011)
The relationship between the % change in platelet adhesiveness (y) and % 
changes in NEFA (x^) and blood glucose (xg) after smoking can be expressed
as follows:- ^ = 0.43x^-3.0x^t30.5
Using this formula, the correlation between the actual and predicted values 
for platelet adhesiveness is significant at the 1% level (r-0.726).
A correlation between changes in plasma NEFA and changes in platelet 
adhesiveness, demonstrated in the sham smoking group has never been shown 
before. The results of this investigation were therefore published
(Murchison & Fyfe, 1966). The finding of significant elevation of
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platelet adhesiveness following sham smoking was a surprise. Although 
the rise in plasma NEFA was not statistically significant it did rise in
5 out of 12 instances in the sham smoking group and there was a significant 
change in the proportions of oleic and palmitic acids. The fact that the 
changes followed a steady basal period suggests that the effects were due 
to sham smoking rather than repeated venepuncture and might possibly have 
been due to the embarrassment of puffing an unlit cigarette. Sham smoking 
has been previously sho\m to produce physiological changes by Irvine and 
Yamamoto (1963) in their investigation of the effects of cigarette smoking 
on cardiac output.
In the smoking experiment, the correlation between the changes in plasma 
NEFA and platelet adhesiveness although still apparent appeared to be 
partially obscured by the rise in blood sugar which correlated negatively with 
the platelet adhesiveness changes. The previous experiments involving 
ACTH in rabbits and surgery in man showed increases in blood sugar accompanying 
the plasma NEFA and platelet adhesiveness changes. The lack of correlation 
in these experiments between changes in plasma NEFA and platelet 
adhesiveness may not have been found because of this. Applying the equation 
obtained in this experiment to those other experiments, however, showed 
that the equation did not hold. The finding of a correlation does not 
necessarily imply a cause and effect relationship. It may be for example 
that catacholamine release could have caused effects, the plasma NEFA, 
blood sugar and platelet adhesiveness changes merely being 'indicators* of 
its release. The increase in proportion of unsaturated fatty acids at 
the expense of saturated fatty acids is another complicating factor if one 
accepts the evidence that unsaturated fatty acids may protect platelets 
from the aggregating effects of saturated acids (Kerr, Pirrie, MacAulay
6 Bronte-Stewart, 1965). This type of change in the fatty acid pattern
is likely to have followed the mobilisation of fat after ACTH in the rabbits 
and after surgery in man, because mobilisation of fatty acids tends to make 
the plasma NEFA pattern more like that of depot fat. Mobilisation of fat 
by various stimuli has this effect (Rothlin, Rothlin & Wendt, 1962; Wood 
Schlierf & Kinsell 1965).
50
It is quite clear that in all the experiments conducted so far, an 
increase in platelet adhesiveness has accompanied an increase in plasma 
NEFA levels. There has been no direct correlation between the two apart 
from in the smoking/sham smoking experiments. This may be because there 
is no relationship between the changes, or if there is, because the 
correlation has been obscured by the alteration in the fatty acid pattern 
or by changes in blood sugar. The former is an unlikely explanation since 
a correlation has been demonstrated in the sham smoking experiment in which 
the fatty acid pattern changed significantly.
The negative correlation between the rise in blood sugar and the change 
in platelet adhesiveness is contrary to the work of Bridges, Dalby, Millar
6 Weaver (T965) who found an increase in adhesiveness associated with the 
rise in blood sugar following oral glucose. They did not show any direct 
correlation between the two however. In this situation one would expect 
the plasma NEFA levels to have fallen and the pattern to have become more 
saturated. Could it have been that this relative increase in plasma NEFA 
saturation was responsible for the rise in platelet adhesiveness? The 
present situation in which endogenous glucose is being mobilised is quite 
different from the changes following oral glucose. The rise in blood 
sugar following smoking has been described before by Lundberg & Thyselius- 
Lundberg (1931) and by Rehder & Roth (1959) who suggested that it may 
have been a stress effect. In the present series it can be attributed to 
smoking per se as it did not occur in the control group.
The finding of Ashby, Dalby & Millar (1965) of a significant increase 
in platelet adhesiveness following smoking has not been confirmed. Although
7 cases showed a considerable rise in platelet adhesiveness following 
smoking, in 5 others in whom there was a marked rise in blood sugar, the 
platelet adhesiveness fell. This effect was most evident in two patients 
who felt nauseated at the end of the smoking period and who showed the 
largest increases in blood sugar in association with delay in the plasma 
NEFA rise. Since Ashby et al.(1965) only measured platelet adhesiveness
it is not possible to explain the discrepancy between their results and the 
present ones. It may be however that in the non fasting state the blood
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sugar response to smoking is less striking.
An increase in the platelet count after smoking has been reported by Grassi 
& Caltabiano (1956). The mechanism is obscure but may be the result of 
adrenaline release (Vaughan-Jones, Ingram, McClure 1963), The present 
results confirm the increase in platelet count following smoking.
Conclusion
Sham smoking was followed by a significant rise in platelet adhesiveness 
and in the proportion of unsaturated fatty acids in the plasma NEFA. The 
changes in the plasma NEFA levels correlated with the changes in platelet 
adhesiveness. This correlation was also evident after smoking but in this 
group there was also a significant increase in blood sugar and this 
correlated negatively with the platelet adhesiveness changes. There was 
also a significant rise in the platelet count following smoking.
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Chapter 10 
Effects of Exercise
Severe exercise has been reported to cause an increase in platelet 
adhesiveness (Ikkala, Myllyla & Sarajas 1966 , Finkel & Curaming 1965) 
while less severe but more prolonged, exercise such as a walk from London 
to Brighton produces a reduction in platelet adhesiveness (Pegrum, Harrison, 
Shaw, Haselton & Wolff, 1967). When standardising a method of measuring 
platelet adhesiveness it is obviously important to determine the effect of 
exercise and how long this effect lasts. In the previously described 
experiments into the effects of surgery and cigarette smoking all the 
subjects were at rest for several hours prior to commencement of the 
experiments. Clearly, particularly when outpatients are involved, the 
necessity of resting and the time required to reach basal conditions must 
be determined in order to get comparable results with the minimum amount of 
inconvenience.
Severe exercise is known to increase the turnover of plasma NEFA, producing 
an initial depression of the plasma leveL followed by a post exercise rebound 
(Friedberg, Sher, Bogdonoff & Estes 1963; Wood Schlierf & Kinsell 1965).
Also, unaccustomed exercise is thought to be a factor leading to myocardial 
infarction (Plotz, 1957). It is possible that fatty acid metabolism and 
platelet deposition could be involved in the mechanism of this association.
The changes in platelet adhesiveness during and after exercise in association 
with the fatty acid changes were therefore investigated.
Method
Nine young healthy male subjects took part in the investigation. One 
subject was unable to complete the exercise schedule because of exhaustion 
and vomiting. This patient was therefore excluded because the results 
on him were incomplete. The average age of the remaining subjects was 25 
years (range 19 - 30 years).
All the subjects were fasting. On arrival at the hospital they were
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placed horizontal on a couch and allowed to rest for at least 20 minutes.
Two basal blood samples (1 & 2) were then obtained 20 minutes apart, prior 
to starting the periods of exercise. The subjects exercised, without 
moving from the horizontal position, using an electrically balanced bicycle 
ergometer. They exercised against a resistance of 1500 kilopond-metres 
for 5 minutes after which a further blood sample (no.3) was taken, A 
further period of exercise followed, lasting 5 minutes again, but on this 
occasion against a resistance of 750 kilopond-metres. Blood was withdrawn 
towards the end of this period of exercise while the subjects were still 
exercising, (sample 4). Thereafter a further 4 samples (no.5-8) were 
taken at 5 minute intervals. Platelet adhesiveness was measured on each 
sample as previously described except that the measurement was commenced 
3 minutes after withdrawal of the blood. P.C.V., plasma NEFA and blood 
sugar were also measured in all blood samples.
Results
The 8 subjects who managed to complete the exercise programme were all 
exhausted, breathless and sweating profusely at the end of it. All however 
recovered quickly (in about 5 minutes) from the effects.
The average results for the 8 subjects are shown in Table XIV,
Platelet adhesiveness rose in 6 out of 8 cases immediately after the 
first period of exercise. The average rise was however not statistically 
significant. After the second period of exercise, platelet adhesiveness 
was elevate1 above the mean basal level in all cases and the average increase 
was statistically significant.(p <C0.01). In the subsequent samples the 
average platelet adhesiveness returned gradually to the basal levels. One 
value was eliminated by Chauvenet’s criterion from the results in sample 6 
as it was unrealistic and would have unduly distorted the average result.
This value was one of 60.3% which was an isolated high value among the other 
7 values for that subject which ranged from 18.2 to 30.7%.
The platelet count rose in every case following exercise. This increase 
was significant at 1% level after the first period of exercise, at the 0.1% 
level after the second period and at the 5% level 5 minutes after termination
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of exercise. The platelet count had returned to the basal level 15 minutes 
after the exercise.
140 1
P U R T ^ L K T  C O U N T 130 -
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Figure 7. Correlation between the percentage changes in platelet
count and packed cell volume (P.C.V.) following exercise
y = 2.Ox - 98.4 (t = 0.657; p <,0.001)
The packed cell volume (P.C.V.) increased in all cases following 
both periods of exercise, returning to the basal level within 10 
minutes of stopping the exercise. .
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The changes in the P.C.V. were statistically significant and correlated 
significantly with the changes in platelet count (r = 0,657, p<C.0.001)
140-1
HON-ADHESIVE 
PLATELET COUNT 
(% CHANGE)
130 -
120 •
IIQ-
23012011090
80 •
P.C.V. (% CHANGE)
Figure 8. Correlation between the percentage changes in "non­
adhesive platelet count" and packed cell volume 
(P.C.V.) following exercise.
y = 2.5x - 154.4 (r = 0.610; p<(0.001)
and with the changes in the non adhesive platelet count (r= 0.610, p<^0.001) 
throughout the experiment.
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There was no correlation with the changes in adhesive platelet count
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Figure 9. Relationship between the percentage changes in
"adhesive platelet count" and packed cell volume 
(P.C.V.) following exercise.
(r = 0.066) or platelet adhesiveness (r " 0.243). These correlations 
are shown in figures 7 to 10.
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Figure 10. Relationship between the percentage changes in 
platelet adhesiveness and packed cell volume 
(P.C.V.) following exercise.
Plasma NEFA levels were suppressed significantly following the first 
period of exercise (p <^0.01). The average level was still low after the 
second period but the difference from the basal level was not significant. 
There was no evidence of any 'rebound' elevation of the plasma NEFA level 
following exercise. Indeed the levels tended to remain slightly below 
the mean basal level. There was no correlation between the changes in 
platelet adhesiveness and the changes in plasma NEFA,
The blood sugar levels did not alter significantly.
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Discuss ion
Ikkala, Myllyla & Sarajas (1966), and Finkel & Gumming (1965) in their 
investigations into the effect of exercise on platelet adhesiveness found 
that exercise produced an increase in platelet count. The former workers 
and their assistants had previously found this in 1961 & 1963, (Sarajas, 
Konttinen & Frick 1961; Ikkala, Myllyla & Sarajas 1963). Biggs, MacFarlane 
& Pilling(1947) also demonstrated an increase but following this both 
Gerheim & Miller (1949) and Sloan & Allardyce (1955) found decreases in the 
platelet count immediately following exercise. Both these groups found 
that the white cell count was elevated in assocation with the decreased 
platelet count. The reason for this finding is obviously that platelets 
were being lost. There is no mention in these papers of special 
precautions, such as siliconising of equipment, taken to preserve platelets.
The most obvious possibility is that the platelets were adhering to 
equipment. This would be more likely to occur after exercise because of 
the likely increase in adhesiveness of platelets. The cause of the increased 
platelet counts after exercise may be that platelets are picked up from 
pulmonary and peripheral capillaries by the dynamic increase in the circulation, 
This is supported by Sarajas, Konttinen & Frick (1961) who found that the 
increases in cardiac output and relative circulation velocity were 
commensurate with those of the platelet count. Although there is a correlation 
between the increase in platelet count and the increase in P.C.V., the fact 
that the slope of the line is greater than 45° shows that the increase in 
platelet count is greater than one would expect simply from P.C.V.changes.
The same goes for the non-adhesive platelet count. This means that the counts 
have risen even when the effects of haemoconcentration have been taken into 
account. The fact that there is no correlation between the P.C.V. and the 
adhesive platelet count or platelet adhesiveness is at first surprising.
This is because the two lines expressing the correlation between P.C.V, and 
platelet count and between P.C.V. and non adhesive platelet count are not 
parallel, the increase in the latter being greater. The relatively greater 
increase in non adhesive platelet count associated with P.C.V. means that 
the P.C.V. changes are not responsible for the increase in platelet
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adhesiveness following exercise.
It will be noted that the levels of platelet adhesiveness in this study 
are lower than in other experiments. This is because the interval between 
venepuncture and measurement of adhesiveness was 3 minutes (c.f. the study 
on the effect of variation of this time interval). This timing was chosen 
so that different manoeuvres such as venepuncturing and the pipetting of 
blood would be out of phase within the design of this experiment.
The increase in platelet adhesiveness following acute exercise has 
been described previously by Ikkala et al. (1966) and Finkel & Gumming 
(1965). The investigation of Pegrum et al. (1967) into the effects of walking 
from London to Brighton and in which there were many uncontrolled variables 
is not comparable. The increase in platelet adhesiveness was associated 
with depression of the plasma NEFA levels suggesting that the relationship 
between the two demonstrated in the smoking/sham smoking experiment is not 
valid. There are, however, two complicating features. Firstly, the 
exercise was very severe and stress would undoubtedly have lead to 
catecholamine release. This could have effected the platelets in view of 
the work of Besterman, Myat & Travadi (1967) and of O ’Brien (1963).
Secondly, since the depression of plasma NEFA is due to increased 
utilisation of fatty acids, the proportion of saturated fatty acids would 
have increased in proportion to the unsaturated fatty acids (Wood, Schlierf 
& Kinsell, 1965). It could be argued that this relative increase in 
saturated fatty acids might have caused the increased adhesiveness in view of 
the previously cited in vitro work incriminating saturated rather than 
unsaturated fatty acids in producing platelet aggregation. This however 
would appear unlikely in view of the fact that the correlation in the 
smoking/sham smoking experiment was demonstrated in spite of an increase 
in the proportion of unsaturated fatty acids which could be argued from 
the same in vitro work to have a protective effect on platelets.
The significance of the increase in platelet adhesiveness after exercise 
and its relationship to the belief that coronary thrombosis is more coimiion 
after unaccustomed exercise is not clear. The increase in platelet 
adhesiveness could be the factor which tips the balance in favour of
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thrombosis in a susceptible subject. Exercise is known to increase other 
coagulation factors such as factors XII and VIII and to shorten the whole 
blood clotting time and the partial thromboplastin time (latridis & Ferguson 
1963) although this effect on the partial thromboplastin time has been 
disputed by Egeberg (1963). On the other hand, exercise also increases 
fibrinolysis (latridis & Ferguson 1963) and any hypercoagulibility may 
thus be counterbalanced. The relationship of platelet adhesiveness to 
thrombosis and the coagulation system is unknown. One might expect that 
surface active factors (XI and XIl) would be related to platelet 
adhesiveness in view of their depending on a common stimulus. This is 
suggested by the work of Sharp (1958), Waaler, (1959) & Jurgens (1962) but 
it is disputed by Barth, Kommerell & Pfleiderer (1966) who showed that 
surface activation did not accelerate platelet aggregation using platelet 
rich plasma in the Payling Wright system. The latter paper would appear 
to be most relevant to the present investigations since the system used 
was similar. However their procedure was fairly complex and one feels 
that there must have been quite a delay between venepuncture and the carrying 
out of the tests so that the possibility of spontaneous platelet aggregation 
(which occurs after 40 - 60 minutes) lowering the initial count and this 
affecting the control must be raised. A further anomaly in that investigation 
is that decreases in adhesiveness are described when increases occur.
Platelet adhesiveness had returned to around the basal levels by 20 
minutes following cessation of exercise. In order that effects due to 
exercise can be eliminated when measuring platelet adhesiveness, subjects 
should be rested for at least 20 - 30 minutes before the blood sample is 
withdrawn. This is obviously of considerable practical importance if 
measurements are to be comparable.
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Chapter 11
Effects of s^ rvatlon In obese subjects
Obesity is acknowledged as being a factor predisposing to ischaemic heart 
disease (Dawber, Kannell, Revotskie & Kagan 1962). Platelet adhesiveness 
in this condition would therefore be of particular interest. In addition, 
rapid weight loss in diabetics is said to predispose to thrombosis (Beckett 
& Lewis 1960). Platelet adhesiveness was therefore investigated in obese 
subjects who had agreed to lose weight rapidly by fasting for 10 days, to 
determine whether platelets are stickier than normal in obesity, and if 
fasting is associated with any increase in platelet adhesiveness.
Method
Sixteen subjects, 3 males and 13 females, were investigated. Two of the 
females underwent a second period of starvation, raising the total number
of episodes of fasting to 18.
Following admission to hospital, the patients remained on a diet similar
to that which they had been having at home. In 10 instances this was
unrestricted and in 8 it was a 600 calorie diet. This diet was continued 
for 3 to 7 days, after which the patients were starved completely for 10 
days. Only non-nutritious fluids were allowed, such as water, black 
coffee or unsweetened lemon tea. Vitamin supplements were not given and no 
drugs were administered. During the refeeding period of 24-48 hours before 
they left hospital, they were given a 600 calorie diet. This was continued 
at home and the patients were seen again after 1 - 4  weeks, in most cases 
after 2 weeks.
Blood samples were taken after an overnight fast on at least 3 occasions 
in most subjects during the basal period. Further samples were taken on day 
2, 4 or 5, 6 or 7, and 9 of the fast. Samples were also taken after an 
overnight fast following refeeding before the patients left hospital, and 
again at the follow-up examination.
Platelet count, platelet adhesiveness, P.C.V., plasma NEFA levels and
pattern, blood sugar, serum cholesterol and serum triglycerides were
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measured on all samples by the methods previously described. Platelet 
adhesiveness was measured 20 minutes following venepuncture. Double
extraction of plasma NEFA was carried out in 8 out of the 18 instances.
/
The patient's weight, urinary ketones and fluid balance were also measured 
Urinary ketones were assessed using Ames Acetest tablets.
Fluid intake and output were charted throughout the period in hospital 
from 8 a.m. each day.
Results & Discussion
Table XV shows the results of the measurement carried out on the blood 
samples. The results are shown as means and standard deviations. The 
weight and the fluid balance changes are shown in Fig.11.
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Figure 11. Mean changes in body weight and fluid balance 
during and after 10 days starvation.
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There was a diuresis which occurred immediately on fasting and which 
gradually subsided during the first week. The weight changes during this 
period paralleled the fluid balance changes and on refeeding there was an 
increase in weight corresponding to the fluid retention. However, by 
the time of the follow-up examination 2 weeks after the fast when the fluid 
balance changes would have corrected themselves a significant amount of 
weight had been lost (7.1 ^ 2.4 Kg).
The pattern of change for serum cholesterol, serum triglyceride, P.C.V. 
and platelet count on fasting were also similar to the fluid balance changes 
and it would appear likely that they merely reflect plasma volume changes. 
The changes in these measurements on refeeding however cannot all be 
explained on this basis.
The serum cholesterol fell out of proportion to the changes in fluid 
balance and P.C.V. on refeeding but the reason for this is not clear. It 
should be noted that the basal serum cholesterol levels were within normal 
limits in all but 3 cases.
While the serum triglyceride levels paralleled the P.C.V. and fluid 
balance changes in these subjects with levels within normal limits, there 
were 2 subjects with high triglyceride levels (307 and 238 mg/100 ml,).
In these subjects the serum triglyceride fell drastically on starvation 
probably because they were likely to have had the commonest form of 
hypertriglyceridaemia namely carbohydrate induced (Ahrens, Hirsch, Oette, 
Farquhar & Stein, 1961). These subjects did not show any evidence of this 
unusual pattern of change affecting the pattern of change in platelet 
adhesiveness.
The P C.V. after its initial rise, fell during the latter half of 
starvation through the refeeding period and again at the follow-up 
examination. Erythropoetin lack which has been shown in rats to occur on 
protein deprivation (Ito & Reissman 1966) may be a factor producing this 
fall during the fast, while on refeeding fluid retention is a further 
factor. The significant fall noted at the follow up examination may be due 
to blood loss resulting from repeated venepuncture.
Although there was no correlation between the P.C.V. and platelet count
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changes, the patterns were similar on fasting, both reaching their highest 
levels between day 4 and 7. The mean rise in the platelet count at the 
follow up examination was not significant because there was great individual 
variation. The increase in some individuals may have been related to the 
stimulus of repeated blood loss (Wintrobe 1961).
Platelet adhesiveness does not appear to be increased in obesity. The
+mean adhesiveness during the basal period was 39.2 - 9.3% which compares
+
with a mean of 43.6 - 11.9% in the group of 35 subjects who were chosen 
at random and who had their adhesiveness measured 20 minutes after venepuncture 
(Table IV).
The effect of fasting on platelet adhesiveness was very variable and 
overall there were no significant changes. Platelet adhesiveness increased 
in 9 and decreased in 9 cases. The pattern of change did not appear to be 
related to the changes in any of the other measurements made. In the case 
of the 2 subjects who undertook starvation on 2 occasions, the pattern of 
change was similar in one, while in the other although the basal level was 
the same, the adhesiveness rose markedly on one occasion and did not change 
in the other. Again there were no corresponding differences between the 
2 fasts in any of the other measurements made in this subject.
Platelet adhesiveness at the follow up examination was not significantly 
different from that before starvation in spite of a significant fall in P.C.V. 
Weight loss therefore does not appear to influence platelet adhesiveness and 
also there v;as no correlation between platelet adhesiveness and the weight 
changes. Plasma NEFA levels were, initially within the normal range although 
other workers (Opie & Walfish 1963 , Glennon, Breck & Gordon 1965) have 
shown that the obese subjects have higher plasma NEFA levels compared to 
subjects of normal weight. In the basal period 16.1% of the apparent NEFA 
value obtained by single extraction was due to substances other than long 
chain fatty acids. During starvation this percentage rose to a maximum of 
28% after 6 - 7  days due to the extraction of ketone bodies. The changes 
in plasma NEFA using the single extraction method paralleled those for the 
double extraction method, although basal and peak levels were higher. There 
was no correlation between plasma NEFA and age, degree of obesity or with
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platelet adhesiveness. The basal plasma NEFA levels however correlated 
negatively with the basal blood sugar levels (r - 0.52 p <(o.05) which were 
normal in all cases. This correlation is compatible with Jenkins (1967) 
theory that in obesity, a state of increased insulin secretion occurs 
during which raised plasma NEFA levels and normal or low blood sugar 
levels are found. Later when pancreatic insufficiency arises fasting 
blood sugars tend to increase.
Despite the evidence that obese subjects do not mobilise fat as well as 
normal (Berkowitz 1964; Heald, Mueller & Daugela 1965; Opie & Walfish 1963 
and Rabinowitz & Zierler 1962) only one subject, as assessed by the rise 
in plasma NEFA, did not mobilise fat adequately. This subject's plasma 
NEFA fell on fasting but nevertheless her platelet adhesiveness rose 
markedly (4-31. 2% by day 5 - 7),
It could be argued that the postulated effects of fatty acids on platelets 
might not become apparent until all the tight binding sites on albumin had 
been saturated (about 1212 jy\Eq. 1), the reason being that only at above this 
level would fatty acids be free to adhere to cell walls. This level was 
exceeded in 8 out of the 16 subjects and yet no significant effect on the 
platelet count or platelet adhesivenesss was apparent in this sub-group- 
In the 8 instances, in which fatty acids were doubly extracted, it must 
be conceded that the levels were generally lower. 1212j^Eq/1 was exceeded 
only twice but again there was no effect on platelets or clinical evidence 
of thrombosis in these subjects.
Starvation produced significant alteration of the plasma NEFA pattern 
which was maximal at day 4 - 5 .  The proportion of oleic acid was increased 
at the expense of palmitic, stearic and to a lesser degree myristic acid 
at this time. The pattern tended to return towards the baseline thereafter 
but refeeding resulted in a further significant increase in oleic and 
decrease in palmitic acid. By the time of the follow up examination, the 
pattern had returned to the baseline. The increase in the proportion of 
unsaturated fatty acids on starvation is the result of increased 
utilisation of NEFA for energy, combined with an increase in mobilisation.
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This has resulted in a transition of the plasma NEFA pattern towards that 
of depot fat.(Table XVI.)
Author
Origin of 
fatty acids
concentrations of fatty acids %
myristic palmitic palmitoleic stearic oleic linoleic
14:0 16:0 16:1 18:0 18:1 18:2
present
study
plasma
NEFA
before
fast
2.3 27.5 7.0 10.0 42.7 10.3
after 
4 - 5  day 
fast
2.2 24.1 6.4 7.9 48.4 10.9
Insull &
Bartsch
(1967)
depot fat 2.7 22.7 5.3 7.0 49.9 9.2
Table XVI Mean changes in serum NEFA pattern before and after 4 -5 day 
fast compared to levels in depot fat.
The fasting blood sugar in the basal period was, as already stated, within 
normal limits. There was no correlation with platelet adhesiveness during 
the basal period nor was there any correlation between the changes in 
platelet adhesiveness and in blood sugar. The blood sugar fell considerably 
on fasting, reaching the lowest level at day 4 - 5 .  It rose thereafter 
but remained significantly below the basal level for the first week of 
fasting. The fall in blood sugar during starvation is due both to 
carbohydrate withdrawal and to the hyperinsulinism which results from 
Ketosis (Madison, Mebane, Unger, & Lochner 1964).
After one day’s fasting, 5 patients had significant Ketonuria while 
4 had a trace. By the next day the majority of patients had moderate
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Ketonuria and only 2 had negative Acetests. All but one had heavy 
Ketonuria by the 6th day and this persisted until the end of the fast.
The Ketosis, like the fall in the blood sugar is due to carbohydrate 
deprivation (Aaar & Bloom, 1963) which results in fat catabolism being 
required to supply the energy demands of the body. Changes in platelet 
adhesiveness did not correlate in any way with the development of Ketosis.
The effects noted on starvation were dominated by the fluid balance 
changes. The diuresis of starvation can be terminated by either 
carbohydrate (Wright, Gann & Albertson 1963) or protein feeding (Katz, 
Hollingsworth & Epstein, 1968). The cause of the diuresis is not understood, 
The fluid loss appears to be limited by secondary aldosteronism which 
appears to be mediated via the renin-angiotensin system (unpublished 
observations).
SUMMARY
There was no evidence of increased platelet adhesiveness in obesity a 
condition Icnown to predispose to ischaemic heart disease. The changes 
in platelet adhesiveness following starvation were very variable but 
overall there did not appear to be any trend, the mean adhesiveness during 
starvation being close to the basal levels. The patterns of change in 
platelet adhesiveness were not related to the changes in plasma NEFA, 
blood sugar, Ketonuria, P.C.V. or serum cholesterol or triglyceride levels. 
Weight loss was not associated with any significant change in platelet 
adhesiveness.
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Chapter 12
Effects of noradrenaline and Isoprenaline administration
In all previously described experiments, the possibility that the 
alterations in platelet adhesiveness could have been related to catecholamine 
release is raised. It has also been suggested that the fatty acids and 
platelet changes could be functions of catecholamine release and therefore 
not be directly related to one another. In view of the known effects of 
adrenaline on platelets both in vivo (Besterman, Myat & Travadi 1967) and 
in vitro (O'Brien, 1963), it is important to know whether the changes in 
platelet adhesiveness are related to plasma NEFA directly or to adrenaline 
directly.
It was considered that the giving of adrenaline to normal subjects could 
be hazardous in view of its ability to produce ventricular fibrillation. 
Noradrenaline is known to have similar although less powerful effects on 
platelets but has little effect on the myocardium. The effects of 
noradrenaline infusion were therefore studied and its effects compared 
with those resulting from sublingual isoprenaline which is thought not to 
affect platelets (O'Brien, 1963).
The effects of noradrenaline and isoprenaline were studied in 6 fasting 
subjects. The noradrenaline group consisted of 5 males, and 1 female 
with an average age of 38,3 years,the isoprenaline group of 2 males and 
4 females with an average age of 25.7 years. All were healthy at the time
of experiment. Their diagnoses were as follows
attempted suicide........ 2
asthma....................2
duodenal ulcer........... 1
Obesity...................1
Parkinsonism,  ........1
normal..................3
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Both experiments were carried out on two of the males. The subjects 
remained horizontal lying on a bed throughout the experiment.
Noradrenaline Experiment
An intravenous saline infusion was set up and the subjects were given 
at least 20 minutes following this before the first blood sample was withdrawn, 
Two blood samples were withdrawn in this basal state% The infusion was then
switched to saline containing noradrenaline in a concentration of 2 mg./litre. 
100ml. of this solution (0.2mg. noradrenaline) was given over a period of 
20 minutes following which 4 blood samples were taken at 5 minute intervals 
while the saline infusion was continued. Pulse rate and blood pressure 
were recorded at 5 minute intervals during the experiments. Platelet 
count, platelet adhesiveness, P.C.V. plasma NEFA and blood sugar were 
measured on each blood sample except in the one subject for whom there 
were no plasma NEFA or P.C.V.results.
Infusion of noradrenaline caused an elevation of the average platelet 
adhesiveness for the whole group persisting to the end of the experiment.
This elevation was statistically significant only at 10 minutes (sample
5) after the noradrenaline. Platelet adhesiveness was increased 
immediately after the noradrenaline (sample 3) in 5 cases out of 6; at 
5 minutes after (sample 4), in 3 out of 6; at 10 minutes after in 5 out of 
6; and at 15 minutes after (sample 6) in 4 out of 6 cases. The average 
results are shown in table XVII.
The platelet count rose sharply in all cases after the noradrenaline 
infusion and this was statistically significant. It fell again quickly 
and 10 minutes after the infusion, the average value had almost reached 
the basal level.
The P.C.V. rose significantly immediately after the noradrenaline 
coinciding with the rise in platelet count. The rise in platelet count 
was greater than could be accounted for by the changes in P.C.V. The 
P.C.V. had also reached the basal level within 10 minutes of the end of the 
noradrenaline infusion.
The plasma NEFA levels increased in all cases at some time following the
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noradrenaline infusion. The changes were not statistically significant 
for any of the samples however because in one out of 5 cases at each 
sampling time, the plasma NEFA level was reduced below the mean basal 
level. When platelet adhesiveness was significantly elevated (sample 5) 
the plasma NEFA levels which had reached a peak in sample 4 were falling. 
There was no correlation between the changes in platelet adhesiveness 
and the changes in plasma NEFA.
Noradrenaline produced a significant rise in the blood sugar levels and 
this was maximal 5 minutes after the end of infusion (sample 4). Thereafter 
the blood sugar tended to fall and by the end of the experiment, 15 minutes 
after the noradrenaline had almost reached basal level.
The effect of the saline infusion can be judged from the changes during 
the basal period. Platelet adhesiveness, the P.C.V., plasma NEFA all tended 
to fall slightly while the blood sugar level rose and the platelet count 
remained unaltered. None of these changes was significant. The dose of 
noradrenaline was sufficient to lower the pulse rate and raise the blood 
pressure during the infusion in all cases. The effects on one subject 
(typical of the others) is shown in Figure 12.
BLOOD 
PRESSURE 
(mm. Hg)
PULSE
(RATE/MIN.)
140  -t
120 -n
lOO -
80  -
60 -
TIME
(MINUTES)
20
X JL JL
25 30  35
NORADRENALINE
40  43 50  55 60
Figure 12.
Effects of 
noradrenaline 
infusion on the 
pulse and blood 
pressure of one 
subject.
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These changes ceased almost immediately on stopping the noradrenaline, 
the blood pressure returning to the basal level while the pulse rate tended 
to 'overshoot' slightly, being very slightly above the basal level in the 
post infusion period.
Isoprenaline experiment
The subjects were given at least 20 minutes to reach basal conditions 
before the first of the two basal blood samples was withdrawn,20 mg. 
isoprenaline was given sublingually during the 10 minutes following 
withdrawal of second basal blood sample. Blood samples were taken 
following administration of the isoprenaline and at ten minute intervals 
thereafter until 4 samples had been obtained. The interval between the 
samples was increased to 10 minutes compared with the 5 minutes for 
noradrenaline, because the effects of isoprenaline as assessed by its 
effect on the cardiovascular system were more prolonged.
The isoprenaline produced a tachycardia with a widening of the pulse 
pressure in all cases. The timing of the cardiovascular effects varied 
but in general commenced after the tablet had been completely dissolved.
120  "I
BLOOD 
PRESSURE loo 
(mm. Hg)
PULSE
(RATE/MIN.)
80  -
6 0  "
40  -
TIME (MINUTES)0
X X
20  25  30 35
( I
ISOPRENALINE
40  45 50 55 60
Figure 13.
Effects on the 
blood pressure 
and pulse rate 
of one subject 
of taking 20 mg 
isoprenaline 
sublingually.
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Fig.13 shows the effect on one of the subjects who was thought to have 
swallowed most of the dose. It appeared therefore that the rate of 
absorption varied from subject to subject, depending on the proportion of 
the dose which was absorbed sublingually. In general post isoprenaline 
blood samples were withdrawn while there were cardiovascular effects of 
the drug present.
Platelet adhesiveness, platelet count, pasma NEFA and blood sugar were 
measured in all blood samples. P.C.V,was not measured in 2 subjects. The 
result for the group is shown in Table XVIII. The results for platelet 
adhesiveness, platelet count, and P.C.V. have been presented with the mean 
basal level instead of the basal values separately because these measurements 
were not carried on one of the basal samples in one subject.
The most striking change in the platelets was a drop in the total count.
This was detected immediately after the isoprenaline in 5 out of 6 instances. 
The change in platelet count was not statistically significant at this stage 
but it was significant 10 minutes (sample 4) (p<C0.01) and 20 minutes (sample
5) (p<^0.05) after the isoprenaline. The platelet count was still depressed 
in 5 out of 6 cases 20 minutes after the isoprenaline.
There were no corresponding changes in the P.C.V. Indeed when the platelet
count was most significantly depressed, the P.C.V. was on average slightly 
elevated. None of the changes in P.C.V.was significant.
Platelet adhesiveness in spite of the fall in the total platelet count 
was elevated in every case at some period following isoprenaline. The 
increase was only statistically significant 20 minutes after isoprenaline 
(sample 5) being present in every case at that time. Thirty minutes (sample
6) after the isoprenaline, platelet adhesiveness was still elevated in 5 
out of 6 instances, the sixth showing practically no change (-2.3%)
The changes in plasma NEFA were not striking. The highest individual 
rise was 208 ^ Eq./I. which compares with the average rise of over 300 J'\Eq./l. 
which followed noradrenaline. The plasma NEFA was elevated in every case 
at some point following isoprenaline the mean levels showing a slight non­
significant rise.
There was slight but significant rise in the blood sugar level during
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the basal period. It occurred in all cases. The changes following 
administration of isoprenaline were more marked than after noradrenaline.
The maximum individual increment being 40mg/100ml, after isoprenaline 
compared with 20 mg./100ml. after noradrenaline. The average increments 
reflect this difference also, being 23,8 mg./100ml. against 16.6mg./100ml. 
The maximum increase in blood sugar occurred much later following 
isoprenaline.
Discussion
When Ahlquist(1948) classified the catecholamine drugs on the basis 
of their action, he found that the two ends of the spectrum were represented 
by noradrenaline and isoprenaline. Noradrenaline stimulated CX 
receptors almost entirely, while isoprenaline stimulated p receptors. 
Adrenaline itself lies in the middle, stimulating both CX and p receptors. 
Noradrenaline, acting onCXreceptors, has very little cardioaccelerator 
action and does not relax bronchial muscle. It does however constrict 
cutaneous and splanchnic vascular beds, resulting in an increase in the 
peripheral resistance producing an increase in the blood pressure and 
reflex cardiac slowing. Isoprenaline acting on p receptors, raises 
the heart rate and dilates the vascular beds in skeletal muscle leading 
to a lowering of the blood pressure and widening of the pulse pressure. 
Isoprenaline because of its p stimulation, dilates bronchial muscle and 
this is its main use therapeutically. These cardiovascular effects of 
noradrenaline and isoprenaline were noted in the present study. The 
effects of isoprenaline both on platelets and on the cardiovascular system 
were delayed compared to adrenaline. This is due simply to the difference 
in the route of administration.
The finding of a greater rise in plasma NEFA following noradrenaline 
than isoprenaline is in line with the observations of Mueller & Horwitz 
(1962) who used equipressor doses. It should be made clear at this point 
that the doses given in the present study were not equivalent on any 
basis. The dose of noradrenaline was approximately the same as that 
used by Mueller & Horwitz (1962) while the dose of isoprenaline was very 
much larger although of course given orally.
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Having found a greater rise in plasma NEFA levels with noradrenaline 
compared to isoprenaline one would expect the blood sugar changes also 
to be similar to those of Mueller & Horwitz who found that isoprenaline 
did not alter the blood sugar. It was therefore a surprise to find 
that the blood sugar changes were greater with isoprenaline. The reason 
for this cannot adequately be explained. It may have been however, that 
some other unknown factor may have pushed up the blood sugar level in 
the present study as this is suggested by the significant rise during 
the basal period. There is a dispute in the literature (reviewed by 
Ellis 1956) concerning the relative ability of isoprenaline to raise 
blood sugar levels. It may be therefore that the present discrepancy 
with the results of Mueller & Horwitz is due to a difference in dosage 
but as pointed out already it, is then surprising that the fatty acid 
responses were similar in proportion.
The two drugs produced markedly different effects on the platelet 
count. The rise following noradrenaline was similar to that usually 
seen following adrenaline. The rise was out of proportion to the P.C.V. 
changes and indicated an absolute increase in the platelet count. In 
rabbits, Sen, Muklerjee & Maiti (1953) have shown that the shortening 
of the clotting time correlates with the increase in the platelet count 
following adrenaline and that both changes can be prevented by exclusion 
of the spleen from the circulation. The increase in the platelet count 
might therefore be due to splenic contraction although whether the spleen 
is capable of this in man is not kno^m. The fall in the platelet count 
following isoprenaline was a surprising finding. As there were no 
corresponding changes in the P.C.V, this would appear to represent a 
real fall in the platelet count. The most likely explanation of this 
fall is intravascular aggregation. Although noradrenaline is known to be. 
able to aggregate platelets in vitro isoprenaline is thought to be 
inactive in this regard ( O'Brien, 1963). In spite of this, the most 
probable explanation is that the isoprenaline aggregated the platelets 
in vivo. This has not previously been reported. An analagous situation
might be the effect of a stimulator of and B receptors in combination
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with an (X blocking drug since this would produce only B stimulation like 
isoprenaline, McClure, Ingram & Jones (1965) have done this using 
phentolamine and adrenaline. They found a 25% decrease in the platelet 
count following the infusion of phentolamine prior to the administration 
of adrenaline. Adrenaline then produced a slight further fall in the 
platelet count but the rise in platelet adhesiveness following adrenaline 
was not prevented. The present experiment is similar in many ways. Beta 
stimulation by isoprenaline produced a fall in the platelet count and 
platelet adhesiveness was increased despite the fall in the platelet count.
The increase in platelet adhesiveness following isoprenaline like the 
other effects on blood sugar, plasma NEFA and the cardiovascular system 
occurred later than after noradrenaline. It is difficult to compare the 
changes in adhesiveness because of the fall in the platelet count after 
isoprenaline. If one accepts that intravascular aggregation of platelets 
occurred and that these would be expected to be the most sticky platelets 
then the true rise in platelet adhesiveness following isoprenaline would 
be much greater than after noradrenaline. Since noradrenaline increased 
plasma NEFA levels more than isoprenaline, and isoprenaline increased 
blood sugar levels more than noradrenaline, it is clear that the positive 
correlation between plasma NEFA and platelet adhesiveness and the negative 
correlation between blood sugar and platelet adhesiveness suggested by the 
smoking experiment do not hold.
The most likely explanation of correlations between platelet adhesiveness 
and plasma NEFA and blood sugar noted in the smoking experiment is that 
all these changes have been results of catecholamine or nicotine stimulation. 
It seems most likely that isoprenaline, noradrenaline and other catecholamines 
act directly on platelets and not via plasma NEFA or blood sugar changes.
SECTION III
THE EFFECTS ON FTATELET ADHESIVENESS 
OF THE OKAL ADMINISTRATION OF SUBSTANCES 
KNOWN TO AFFECT LIPID METABOLISM
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Chapter 13
Effect of administration of oral fat.
Patients with ischaemic heart disease have a more intense and more prolonged 
lipaemia than control subjects following a standard fat meal. This appears 
to be due to differences in the absorption of the fat from the alimentary 
tract since no difference between patients and controls can be demonstrated 
after fat given intravenously (Bouchier & Bronte-Stewart,1961). Philip 
& Payling Wright (1965) have shown that platelet adhesiveness is elevated 
2 hours after a fat meal and have attributed this to the lipaemia although 
they did not show any correlation between the two. They also speculated 
that fatty acids might be involved in producing the elevation in platelet 
adhesiveness. The opportunity to study platelet adhesiveness changes 
under conditions known to be abnormal in ischaemic heart disease - namely 
alimentary lipaemia - was therefore taken.
Method and Results
Seventeen patients were investigated during the lipaemia resulting from 
a liquid meal containing 75 G of milk fat (Nestles Rich Cream 325G; complan 
35 G ; glucose 15 G; water to 750ml.). The average age of the patients was 
48,5 years (range 26 - 67 years) and there were 14 males and 3 females in 
the group. The diagnoses were as follows
ischaemic heart disease......6
peripheral vascular disease..5
normal...... ................ 2
hernia.  .....................1
respiratory infection   1
asthma........................1
congenital heart disease.....1
The patients were fasted overnight. Following the withdrawal of a basal
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blood sample, the liquid fat meal was given. Blood samples were withdrawn 
at 1 hour, 2 hours, 4 hours, 6 hours and 8 hours thereafter. Throughout 
the experiment the patients remained in bed and were not allowed to smoke 
or eat. Platelet count, platelet adhesiveness, blood sugar, plasma NEFA, 
serum triglyceride and serum cholesterol were measured on all blood samples.
The average results are shown in Table XIX,
Blood sugar levels rose in all cases and were significantly elevated 
1 hour, 2 hours and 4 hours after the fat meal. Even at 8 hours the mean 
level had not returned to the baseline, being elevated in 9 cases.
The plasma NEFA level fell initially, the dep:ess ion being statistically 
significant at 2 hours. Following this however the levels became 
statistically elevated and remained so to the end of the experiments. The 
peak in the fatty acid curve was at 6 hours.
Serum triglyceride rose to a peak at 4 hours and then declined, almost 
reaching the baseline by 8 hours. The elevation was statistically significant 
at 1, 2, 4 and 6 hours.
Serum cholesterol also rose, the mean level being at its highest at 2 hours 
The elevation was statistically significant at all times after the fat meal.
The platelet count showed only minor insignificant fluctuations.
Platelet adhesiveness was raised above the basal level at 2 hours in 12 
out of 17 instances and this change was significant at the 5% level. None 
of the changes at the other times was significant. There appeared to be 
basically 2 types of response with regard to platelet adhesiveness. In 
one group, after the initial elevation at 2 hours, platelet adhesiveness 
was depressed at 4 hours returning to the basal level at band 8 hours. In 
the other group, platelet adhesiveness continued to rise to a peak at 4 
hours thereafter declining. The changes in the 2 groups, consisting of 9 
and 8 individuals each, are shomi in Figure 14. The groups did not differ 
in age, sex or diagnostic composition. The first group had initially higher 
platelet adhesiveness levels but this difference was not significant. The 
blood sugar and plasma NEFA responses of the groups were similar but the 
second group tended to have a higher and more prolonged lipaemia as measured
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by the serum triglyceride. The differences between the groups were not 
significant in any respect and it should be emphasised that the groups 
were formed merely on the basis of whether platelet adhesiveness was 
elevated or depressed at 4 hours.
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Figure 14.
Mean results for 
platelet adhesiveness, 
serum triglyceride, 
plasma NEFA and blood 
sugar for 9 subjects 
whose platelet 
adhesiveness was 
depressed 2 hours 
after a fatty meal 
(X-X) compared to 
those for 8 subjects 
in whom platelet 
adhesiveness was 
increased 2 hours 
after a fatty meal
TIME AFTER FAT MEAL (HOURS)
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Discussion
The present results confirm the finding of Philip and Payling Wright 
(1965) of elevation of platelet adhesiveness 2 hours after a fatty meal. 
Blood sugar, serum cholesterol, serum triglyceride are significantly 
elevated at this time while plasma NEFA is significantly depressed. The 
platelet changes following the meal were irregular and basically followed 
the two patterns already described. The changes in platelet adhesiveness 
did not follow or correlate with the changes in any of the other 
measurements. If the lipaemia was responsible for the platelet changes, 
then one would have expected that platelet adhesiveness would have reached 
a peak at 4 hours or later. This did not happen. The suggestion made 
by Philip & Payling Wright that increase in the plasma NEFA levels might 
be responsible also would appear unlikely since plasma NEFA levels were 
depressed at this time. In view of the work of Bridges, Dalby, Millar 
& Weaver (1965) showing that platelet adhesiveness is elevated following 
glucose alone, it is interesting to note that the blood sugar levels were 
also elevated at 2 hours. Here again, the platelet adhesiveness was not 
elevated at 1 hour and 4 hours, when the blood sugar was raised.
It was decided to investigate the effect of oral glucose on platelet 
adhesiveness because the reported elevation of platelet adhesiveness, 
following glucose had been denied by Bennett (1967) using Hellem's & 
Borchgrevink's methods and because the effect of glucose could be 
responsible for the rise in platelet adhesiveness after the fat meal in 
the present experiment.
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Chapter 14 
Effects of oral glucose
Ten subjects were investigated. The group consisted of 5 males and 
5 females with an overall average age of 57.4 years. The diagnoses were:-
diabetes............. .. 3
asthma......................  2
normal.............. ....... 2
ischaemic heart disease...... 2
peripheral vascular disease.1
These subjects were fasted .overnight and drank 50G of glucose in water 
after a basal blood sample had been taken. Blood samples were then taken 
half hourly for 2% hours. Throughout this period the subjects remained 
in bed and were not allowed to eat, drink or smoke. Platelet count, 
platelet adhesiveness, blood sugar and plasma NEFA levels were measured 
on each sample.
The mean results for the 10 subjects are shown in Table XX.
The blood sugar results give a mean curve which is ’diabetic'. There 
were only 3 diabetics in the group however. The very high levels in two 
of these (fasting - 235mg./100ml. which a peak of 552mg./100ml. and fasting 
" 155mg./100ml. with a peak of 251mg./100ml.) has produced this effect.
Of the remaining 'normal' curves, 3 had a peak at 30 minutes and 4 at a 
peak of 60 minutes.
The plasma NEFA levels of the diabetics were not higher than the others. 
Glucose produced suppression of plasma NEFA in all cases. The lowest 
average for plasma NEFA level s occurred at 1% hours, but in 2 normals and 
1 diabetic the lowest level had been reached by 1 hour. The mean depression 
of the plasma NEFA was significant at 1, 1% and 2% hours.
Mean platelet adhesiveness rose progressively following the administration 
of glucose. The elevation became significant at 1% hours and at 2% hours.
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The increase at 2 hours just failed to be statistically significant.
At this time however, the initial platelet count had fallen in 9 out of 
the 10 instances and this probably explains the discrepancy. The small 
changes in the initial platelet count were not significant despite the 
fall in 9 out of 10 instances at 2 hours. The rise in platelet adhesiveness 
was in general later than that of the blood sugar, the peak level being 
recorded at 2h hours, in 6, 2 hours in 1, 1% hours in 2 and % hour in 1.
There was no correlation between these changes or between those of 
platelet adhesiveness and plasma NEFA.
Discussion
The finding of a rise in platelet adhesiveness after ingestion of 
glucose confirms the work of Bridges, Dalby, Millar & Weaver (1965) who 
used basically the same method. The results differ in the timing however. 
Bridges et al. found that the peak of the glucose curve generally corresponded 
to the maximal adhesiveness but that towards the end of the experiment (2 hours 
in their case) adhesiveness was tending to become less when the blood sugar 
levels particularly in the diabetics, were still considerably raised. Platelet 
adhesiveness in the present series tended to rise later than the blood sugar. 
The reason for this discrepancy is not clear but it probably indicates that 
the blood sugar changes are not responsible for the changes in platelet 
adhesiveness. This impression is borne out by considering the one subject 
who did not show an increase in platelet adhesiveness following glucose.
This subject increased her blood sugar from a fasting level of 77mg./100ml. 
to a peak level of 202rag./100ml. at 1 hour, this being the greatest increase 
in blood sugar in the non-diabetic group. The increase in platelet 
adhesiveness following glucose may be only demonstrable using the Payling 
Wright method since Bennett (1967 b) was unable to find any change using 
Borchgrevink's 'in vivo' method or using the method of Hellem. An 
alternative explanation however would be that the discrepancy is due to 
timing. This appears the more likely explanation. Bennett compared only 
basal platelet adhesiveness with that 'approx. 1 hour, after the ingestion 
of 50G glucose'. The present results show a rise in platelet adhesiveness
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subsequent to 1 hour and like Bennett's study, show no significant change 
in platelet adhesiveness at 1 hour.
The fall in the initial platelet count in 9 out of 10 cases at 2 hours 
probably explains why the increase in adhesiveness just failed to be 
statistically significant at that time. The fall in the platelet count 
because of its transient nature is likely to have been due to the loss 
of platelets in the process of withdrawal of the blood rather than due to 
intravascular aggregation. This fall in the platelet count is consistent 
with the increase in platelet adhesiveness since one would expect that 
loss of platelets would be more likely to occur when adhesiveness is 
increased.
There was no correlation between the changes in plasma NEFA and those 
of platelet adhesiveness. The lack of correlation is best seen again in 
the subject whose platelet adhesiveness did not alter. She had the highest 
initial plasma NEFA level (917 ^(Eq./1.) and showed the greatest reduction 
(to 279 j^Eq./l.) The fact that this subject had the highest rise in blood 
sugar and the greatest fall in plasma NEFA and yet did not alter her 
platelet adhesiveness is completely contrary to the expected effects if 
one believed that the relationships demonstrated in the smoking experiments 
were valid.
The findings of increased platelet adhesiveness at approximately 2 hours 
after glucose and after fat, with no obvious relationship to either glucose 
or lipid levels, suggest that the phenomena may be due to a common mechanism 
The reason for this increase is not clear but the implication that platelet 
adhesiveness should only be measured in the fasting state when comparing 
one subject with another is important.
Nobody, as far as I am aware, has reported any other evidence of 
hypercoagulability after the administration of oral glucose. Indeed, 
Isapogas, Cotton, Flute & Murray (1962) found increased fibrinolysis 
following the ingestion of 50G of glucose. The situation is quite 
different with regard to oral fat. Fullerton, Davie & Anastasopoulos (1953) 
have shown that the clotting time in non-water-wettable test tubes was 
shortened during the lipaemia following oral fat. Chylomicrons have been
shoTvn to play an important part in blood coagulation (Poole 1955b) in vitro
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but Husom (1961) has suggested that the effects may be due to the 
addition of platelets along with chylomicrons. Swank (1959) has demonstrated 
an increase in blood viscosity and red cell aggregation following fat 
feeding in dogs. This occurred later than the peak of the lipaemia. He 
also demonstrated accompanying changes in the platelet count and in the 
clotting time. In the presence of red cell aggregation, the likeliest 
explanation of the fall in the platelet count is intravascular aggregation.
The present study does not suggest that there is any platelet aggregation 
or increase in adhesiveness after the peak of the lipaemia. It is interesting 
that Begg & Hearns (1967) using a fat meal identical to the present one,were 
unable to demonstrate any change in blood viscosity in a group of 24 subjects, 
containing 12 with ischaemic heart disease, again suggesting that there is 
no significant red cell aggregation in man at this time, Intravascular 
agglutination and plugging in the bulbar conjunctiva following fat feeding 
has been seen by Williams, Higginbotham & Knisely (1957) in men with 
ischaemic heart disease while in normal subjects, there was little or no 
agglutination. Of the 11 subjects with evidence of vascular disease in 
the present study 7 showed slight increases in platelet count. There is 
thus no evidence of platelet aggregation. Philip & Payling Wright (1965) 
however did find a small decrease in the platelet count 2-2% hours following 
oral fat and they speculated that this may have been due to intravascular 
aggregation. The present study agrees with their finding of increased 
adhesiveness at this time. Besterman ec al. however did not find any 
alteration in the platelet count in their study. Their results have not 
been presented in detail, only showing the changes in adhesiveness and 
triglyceride in 2 out of 40 fat tolerance tests. From these tests, the 
increase in adhesiveness appeared to have been present between 3 and 7 hours, 
but did not appear to be related to the degree of lipaemia. In view of 
all these conflicting patterns following oral fat, it would appear that the 
most obvious explanation is that different types of meals have different 
effects. It is interesting that with regard to clotting at least several 
groups of workers are agreed that the degree of saturation of the ingested 
fats does not affect the results (Merskey & Nossel 1957), O'Brien (1957),
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McDonald & Fullerton (1958).
Summary
Ingestion of a glucose load or a fatty meal is followed by an increase 
in platelet adhesiveness. This increase in adhesiveness does not appear 
to be related either to the blood sugar or serum lipid changes.
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Chapter 15
Effect of dietary sucrose on serum lipids and platelet adhesiveness
Since ingestion of glucose is followed by an increase in platelet 
adhesiveness, one might expect sucrose to have a similar effect. Yudkin 
& Norland (1967) have shown that subjects who have had a myocardial 
infarction consume more sucrose than the general population. They have 
suggested on the has is of this, that sucrose may be an aetiological factor 
in ischaemic heart disease. It was therefore decided to investigate the 
effect of sucrose on a long term basis on platelet adhesiveness to determine 
if platelet adhesiveness might be the link relating sucrose to ischaemic 
heart disease. Could in fact the increased adhesiveness found in subjects 
with ischaemic heart disease be due to increased sucrose intake?
Another possibility might be that sucrose is related to ischaemic heart 
disease via seruim lipids since Macdonald (1964, 1965 & 1967) has shown that 
these are elevated by sucrose compared to starch. Serum lipids were
therefore measured not only to determine the effect of sucrose on them but 
in addition to determine if there was any relationship between the serum 
lipid and platelet adhesiveness changes.
Five subjects, 3 males and 2 females, were investigated. Their ages 
ranged from 49 to 85 with a mean of 63 years. Their diagnoses were:-
ischaemic heart disease.....2
cerebrovascular accident....1
Parkinson's disease......... 2
Following admission to hospital, the subjects ate the ordinary ward 
diet for 2 weeks. Their calorie requirements were assessed during this 
period. During the subsequent experimental period of 8 weeks, the calorie 
intake was kept constant. During one 4 week period, 70% of the carbohydrate 
was supplied as sucrose while during the other 4 week period, although the 
proportions of carbohydrate, protein and fat were not altered, sucrose was
not given.
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Throughout the whole period, 40% of the calories were given as fat, 15% 
as protein and 45% as carbohydrate. The sucrose free diet was given first 
in three instances. The effect of an isocaloric interchange between sucrose 
and starch could thus be determined. Blood samples were taken from all 
subjects thrice weekly after an overnight fast. Serum cholesterol, serum 
triglyceride, plasma NEFA, blood sugar, platelet count and platelet 
adhesiveness were determined in each sample.
The average results for the 5 subjects for each period are shown in
Table XXI. The average results for each period for each of the 5 individuals
is shown in Table XXII. Taking the overall results first, it can be seen
that the only measure which changed significantly was the fasting blood 
sugar. This was higher on the diet containing sucrose. Considering
each individual, this change in the blood sugar was significant in 2 and 
just failed to be significant in other 2 (t = 2.042 ( for pK0.05, t " 2.109) 
and t " 2.082 (for p <(0.05, t = 2.093)).
Plasma NEFA, serum cholesterol and serum triglyceride did not vary 
significantly overall or for any individual between the ’sucrose free’ 
and sucrose periods.
Platelet count was higher in all cases when on the sucrose diet. The 
variation was significant for only one individual (L),
There was no change in platelet adhesiveness between the two periods.
One individual (Mcl) however did shown a significant chapge, the adhesiveness 
being significantly greater when on the ’sucrose’ diet. The other subjects 
showed small insignificant changes and the overall means for each period were 
very close together.
Discussion
The mean platelet count was higher in all 5 individuals when they were 
on the diet containing sucrose. This was significant however in only 1 case 
(L). The reason for this increase is not clear. Blood volume changes 
might be involved. Alternatively one might expect an increase in platelet 
count if the platelets were less sticky and therefore less liable to aggregation 
and deposition both on endothelium and apparatus. This cannot be the
Without
Sucrose
With
Sucrose
t Significance
cholesterol
mg% 238.x 37.4 243.2 43.8 0. 837 N.S.
triglyceride
mg% 106.6 - 46.2 108.1 - 47.5 0. 962 N.S.
NEFA 435.9 t 125..9 420.1 - 130.8 0.061 N.S.
Blood glucose 
mg% 65.8 t 8.1 72.2 t 6.6 4.300 p <0.001
platelet 
adhesiveness % 34.4 t 9.0 34.1 t 11.3 0.131 N.S.
Weight
Kg
58.3 t 9.0 58.4 i 9.1 0.025 N.S.
TABLE XXI Average results (with standard deviations) 
for the 5 subjects showing the effects of 
the isocaloric substitution of starch by 
sucrose.
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explanation however since considering the results overall there was no 
change in platelet adhesiveness between the two periods. Indeed one 
subject showed a significant increase in platelet adhesiveness when on 
sucrose and yet the increase in platelet count was still apparent. Why 
did the adhesiveness increase in one case (Mcl) and not in the others?
Again the reason is not clear. It is interesting that in this subject, 
the fasting blood sugar was significantly higher when on sucrose. In 
view of the work of Bridges et al. relating platelet adhesiveness to 
blood sugar levels it would be tempting to try and relate the two changes. 
Unfortunately this relationship does not hold since all the subjects 
showed small increases in the fasting blood sugar (this being significant 
in one other and Just failing to reach significance in the other two) with 
if anything a tendency for platelet adhesiveness to fall slightly in these 
cases.
The present study fails to support the finding of Macdonald and his 
coworkers (1964, 1965 & 1967) that the isocaloric interchange of sucrose 
with starch produced lowering of the serum triglyceride levels. Kuo &
Bassett (1965) had supported this view by finding that replacement of 
starch by sucrose raised serum triglycerides. Rifkind, Lawson & Gale 
(1966) also found that triglyceride levels were lowered by sucrose-free 
diet. Careful examination of these studies suggests that weight changes 
may have been involved in producing the lipid changes, so that in fact 
the 'sucrose free' diets were weight reducing diets. This view was put 
forward with the preliminary results of this study (Dunnigan, Fyfe & Sawers 
1967). The failure of sucrose to have any extraordinary action on serum 
lipids has also been found by Lees (1965);Farquhar,Frank, Gross^Reaven (1966); 
Anderson (1967) and Antonis (1967). The findings of these workers agree with 
the present results and it would appear likely that sucrose does not have 
any lipid-raising property out of proportion to that of other carbohydrates. 
Doubt is present concerning the place of sucrose in the aetiology of ischaemic 
heart disease. The findings of Yudkin and his coworkers (1964 & 1967) that 
subjects with ischaemic heart disease take more sucrose than controls has 
been denied by Little, Shanoff, Csiraa, Redmond & Yano (1965) and also by Papp,
Padilla & Johnson (1965).
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Yudkin has suggested that the discrepancy between his own work and that 
of Little et al. may be due to the time interval between the study and 
the patient's myocardial infarction. To support this, he has shown that 
his patients reduce their sucrose intake voluntarily after their attack 
so that by 18 months after the attack their sucrose intake is not greater 
than that of controls. The study of Papp et, al. was conducted in 18 out 
of 20 instances within 6 months of the subject's myocardial infarction and 
so this criticism does not hold in this case. Support for Yudkin's ideas 
comes from the work of Osancova, Hejda and Zvolankova (1965) and of Cohen,
Bavly & Poznanski (1961), Osancova et al. have shown a positive correlation 
between the mortality from cardiovascular disease and the sugar comsumption 
(r = 0,7672, p = 0.01) Cohn et al. have found that Yemenites resident in 
Israel have a much higher sugar consumption than those staying in the Yemen 
and also a higher incidence of ischaemic heart disease. The place of 
sucrose in the aetiology of ischaemic heart disease is therefore uncertain. 
Certainly there is growing evidence that it does not raise serum lipids out 
of proportion to other carbohydrates. It may on the other hand cause a 
relative impairment of glucose tolerance.
The finding that fasting blood sugars were greater on a diet containing 
sucrose is extremely interesting. Relative impairment of glucose tolerance 
while on sucrose compared to starch has been demonstrated by Cohen, Teitelbaum, 
Balogh & Groen (1966). The present finding also suggests that glucose tolerance 
may be relatively impaired on a sucrose diet compared to a sucrose fr^e diet. 
This would seem a reasonable deduction since Frethem (1963) has shown that 
fasting blood sugar levels can be taken as an index of carbohydrate tolerance. 
Further investigation into this suggestion of impaired glucose tolerance 
was carried out. Essentially the same experiment was carried out in a further 
8 subjects but serum insulin levels were measured in addition to blood 
sugars and glucose tolerance tests were done once weekly. Table XXIII shows 
the results of this experiment.
There was a significant difference between the fasting blood sugars on 
the sucrose compared to the sucrose free diet. This was significant 
individually in 3 out of the 8 cases making a total of 5 out of 13 when
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the original 5 cases already described were added. Although the mean blood 
sugar values were slightly higher at each point during the glucose tolerance 
test there was no significant difference at any time or when the areas under 
the curves were compared. There was no difference between the fasting 
serum insulin concentrations on the 2 diets nor did the serum insulin levels 
become significantly different between the diets at any time during the glucose 
tolerance tests although the mean levels, like those for the blood sugars 
were higher at each point during the glucose tolerance test during the 
sucrose period. This suggests that the increase in fasting blood sugar 
during the sucrose diet might be due to increased insulin resistance. The 
elevation of the fasting blood sugar associated with unchanged fasting 
serum insulin levels, and also the greater mean blood sugar and serum 
insulin responses to glucose, during the sucrose period would fit into this 
concept. Glucose tolerance tests were only done once weekly compared to 
thrice weekly for the fasting specimens, and this may account for the failure 
of the difference between the glucose tolerance curves between the dietary 
periods to be statistically significant. In spite of this failure it is 
striking that the mean blood sugar and serum insulin responses were greater 
at every point during the glucose tolerance test during the sucrose diet.
It is surprising if the increased fasting blood sugar levels during 
the sucrose diet do represent impaired carbohydrate tolerance, that the 
differences between the glucose tolerance tests are not more striking since 
one normally uses a glucose tolerance test to demonstrate impaired 
carbohydrate tolerance rather than fasting blood sugars, A reason for this 
could be that a physiological balance has been struck between limiting the 
blood sugar response to oral glucose and increasing the insulin response.
If either the blood sugar response or the serum insulin response to glucose 
had been fixed between the two dietary periods then the change in the other 
might have been significant.
A further possibility is that the insulin mechanism might not be 
involved in causing elevation of the fasting blood sugar. At no time were 
there significant differences in the plasma insulin levels between the two
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dietary periods nor were the glucose levels during the glucose tolerance 
tests significantly different. It could therefore be argued that there is 
no evidence of impaired carbohydrate tolerance or increased insulin 
resistance depending on how one interprets the small non significant 
differences in serum insulin and blood sugar following glucose.
Cohen et al. (1966) found impaired glucose tolerance when on a 
sucrose diet but those workers did not measure serum insulin levels.
The cause of the probable increase in insulin resistance is not clear.
The present study has shown that it is not due to alteration of plasma 
NEFA levels which are known to affect insulin resistance nor is it 
associated with any change in serum cholesterol or serum triglyceride.
The most likely explanation is that it is a direct effect of sucrose on 
carbohydrate metabolism,
Summary
Sucrose in the diet, which is thought by some to be a factor 
predisposing to ischaemic heart disease, was not associated with increased 
platelet adhesiveness. Fasting blood sugars were significantly higher when 
on a sucrose diet while fasting serum insulins were unchanged. The blood 
sugar and serum insulin responses to glucose tended to be greater when on 
the sucrose diet. Increased insulin resistance therefore appeared to be 
present during the sucrose diet but the cause for this is not apparent.
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Effects oft^llnolenic acid
The effect of mobilisation of endogenous fatty acids on platelet 
adhesiveness has been studied in some detail in Section 2 of this thesis. 
The next question to be considered - and this could have therapeutic 
application - is whether exogenous fatty acids given orally affect platelet 
adhesiveness. Stimulus to this line of research was given by Owren's 
group when they demonstrated that linseed oil appeared to lower platelet 
adhesiveness. Although this work has now been withdrawn, the in vitro 
studies of Kerr, Pirrie, MacAulay & Bronte-Stewart (1965) and of Mahadevan, 
Singh & Lundberg (1966) show that linolenic acid appears to protect 
platelets from aggregation by other fatty acids. A preparation containing 
‘^ linolenic acid was made available by the Calmic Co. for study. This was 
the preparation "Calmic 131A" which is obtained from the seeds of evening 
primrose (Oenothera lamarkian). The composition of this preparation is;-
palmitic acid 6.5%
stearic acid 1.5%
oleic acid 10%
linoleic acid 73%
Klinolenic acid 9%
This drug therefore contains predominantly unsaturated fatty acids and 
might be expected to lower serum lipid levels in addition to any direct 
effect it might have on plateleps. The effects of this preparation on 
platelet adhesiveness, plasma NEFA, serum cholesterol, serum triglyceride 
and blood sugar were therefore studied in 6 subjects. The average age of 
the group was 53 years (range 40 - 67). All were males and all had 
ischaemic heart disease except for one subject who was healthy. The 
investigation was carried out on an outpatient basis. The subjects were 
seen on three occasions before commencing Calmic 131A. They then
92
commenced the drug in a dose of 3 capsules (825 mg) a day for 2 weeks.
They were seen again on 3 occasions during the second week of treatment.
On each occasion, the subjects were seen at 9 a.m. in the fasting state.
Blood was withdrawn for the platelet and lipid studies on each occasion.
Results
Table XXIV shows the mean results (^ S.D.) for the group as a whole 
before and during Calmic 131A administration. The only change which was 
significant was in serum cholesterol, which fell. The means for plasma 
NEFA, serum triglyceride, blood sugar and platelet count were virtually 
unchanged. Platelet adhesiveness did not change significantly but tended 
to fall. Table XXV shows all the platelet adhesiveness results for each 
individual together with the means for both periods for each subjects. ^
It can be seen from these results that platelet adhesiveness was 
varying spontaneously during both periods. Although the mean value for 
adhesiveness while on Calmic 131A was lower in the majority of subjects, 
this cannot be attributed to the drug because the degree of variation 
within each period was greater than the variation between the periods.
For example, for subject 6, platelet adhesiveness varied from 25.4 to 
51.8 during the basal period and from 30.4 to 46.4 while on Calmic 131A, 
with a difference between the means for each period of only 2.7%. The overall 
changes were similar. The difference between the means for samples (bottom 
line Table XXV) during the basal period was 4%, during treatment was 4.4% 
and between the basal and treatment periods only 4.1%.
Discussion
The most striking finding in this experiment was the variability of 
platelet adhesiveness from day to day. As a result of this, changes in 
platelet adhesiveness attributable to taking the drug would have to be very 
large in order to be significant. The variability from day to day was also 
noticeable in the studies into the effects of total starvation and of sucrose. 
This variability will be discussed in detail later in this thesis. The mean 
difference in adhesiveness between the 2 periods was 4.1% and in the light
Before During
Treatment Treatment.
platelet count ^ J»
X 10 /cmm. 167.4 ™ 40 167.9 - 42
platelet adhesiveness % 41.2 t 9.x 37.1 - 5.8
plasma NEFA '^^ Eq/1. 433 - 90 457 t 104
blood sugar mg/lOOml,
H-
73 - 4 70 t 4
serum cholesterol mg/100ml 274 ~ 40 + ■ * 249 " 29
serum triglyceride mg/100ml 94 33 93 i 25
TABLE XXIV Effects of Calmic 131A in a dose of 3 capsules/day. The
results are the means and standard deviations for 6 subjects
p<0.05*
subject before treatment dur ing treatment
1 2 3 Mean 1 2 3 Mean
1 30.7 61.4 65.3 52.5 37.3 25.3 32.3 31.6
2 41.1 45.5 49.0 45.2 37.9 37.1 20.5 31.8
3 42,3 45.4 53.0 46.9 36.4 53.0 46.1 45.2
4 40.8 29.4 14.7 28.3 24.1 36.7 38.0 32.9
5 35.5 31.4 31.0 32. 6 41.7 43.7 41.3 42.2
6 51.8 47.3 25.4 41.5 46. 4 39.5 30.4 38.8
MEAN 40.4 43.4 39.4 41.2 37.3 39.2 34.8 37.1
TABLE XXV Platelet adhesiveness (%) results before and during 
Calmic 131A administration.
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of the day to day variation, is clearly not significant. Millar and Wilson 
(1968) also failed to find any significant change in platelet adhesiveness 
due to Calmic 13lA. They did however find small insignificant changes 
in platelet adhesiveness on Calmic 131A in a dose of 6 capsules/day which was 
associated with a fall in serum cholesterol. There was a significant fall 
in serum cholesterol in the present experiment but there was no correlation 
between the changes in serum cholesterol and the changes in platelet 
adhesiveness. The fall in serum cholesterol is likely to have been due to 
the administration of unsaturated fatty acids. Seasonal variation is 
unlikely to have been a factor in such a short term experiment but it should 
be noted that the experiment was performed in May and June 1966 and that serum 
cholesterol was tending to fall at this time of the year (Fyfe,Dunnigan, 
Hamilton & Rae 1968).
Since the withdrawal of Owren's work on linolenic acid, there has not been 
any support in the literature for the suggestion that platelet adhesiveness 
might be lowered by linolenic acid. At a clinical level, Christie, Conway 
& Pearson (1968) have suggested that Calmic 13lA improves the performance 
of subjects with intermittent claudication. Their results were clouded 
to some extent by a placebo effect but their conclusions appear from their 
data to be valid. It is difficult to understand what mechanism might 
underlie the improvement in performance but further investigation to confirm 
their work would appear to be indicated.
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Chapter 17
• Effect of cloflbrate
Clofibrate is the ester of a short chain fatty acid. Its structural 
formula is:-
CH3
^  -  .-3
CH3
Cl — \ o  "• c " GooC„H
This substance alone or in combination with androsterone has been showTi 
to be capable of lowering serum cholesterol and triglyceride levels and 
also platelet adhesiveness (Carson, McDonald, Pickard, Pilkington, Davies 
& Love (1963 & 1966) and Symonds, de Toszeghi & Cook (1964). More recent 
investigations have failed to demonstrate lowering of platelet adhesiveness 
however (O'Brien & Heywood 1966; Millac, Caspary & Prineas 1967). The 
question whether or not clofibrate affects platelets is therefore not 
established. If clofibrate does lower platelet adhesiveness, it could do 
so either by direct action on platelets or as a secondary effect via 
changes in serum constituents such as lipids (Gilbert & Mustard 1963).
The effect of clofibrate in a dose of iG/day was therefore studied in 
6 in patients. The average age of the group was 50.5 years (range 40 - 
64) and there were 4 males and 2 females. All had ischaemic heart disease. 
Following admission to hospital, the patients were maintained on the ordinary 
ward diet. On at least three occasions during the basal period blood samples 
were taken after an overnight fast with the patient still in bed.
Clofibrate (Atromid-S) was then started in a dose of IG/day and the progress 
of the subjects followed by taking blood samples under similar conditions to 
the basal period. The timing of the samples taken while on treatment was 
variable but can be assessed from Table XXVI which shows all the platelet 
adhesiveness results for the 6 subjects. Table XXVII shows the mean 
results during the basal period together with the changes in platelet count, 
platelet adhesiveness, plasma NEFA, blood sugar, serum cholesterol and serum 
triglyceride from the mean basal level. The results are shown as differences
Basal clofibrate iG/day
Weeks - 2 - 1 1 2 3 4
S.W. 43.2 47.5
47.4
- 45.6 - 31.9
A 31.6 
29.2
33.6
44.7
40.8
48.2
33.5
43.8
32.2
38.5
42.7
37.9
M.W. 43.9
39.3
41.2
37.2 
40.0
54.4
55.5
45.2
35.7
35.8 
64. 4
H 30.1
33.7
28.6
36.8
35.6
40.4
32.4
M 39.3 
29.0
22.3
35.3
23.9
23.8
36.1 37.3
27.8
32.5
McD 56.4 
56. 6
48.3 40.7
23.0
43.1
52.8
46.7
32.9
46.4
TABLE XXVI Platelet adhesiveness results (%) before and 
during clofibrate therapy for 6 subjects.
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on this occasion because of the variability in the timing of the venepuncture.
Results and Discussion
The platelet count rose during treatment with clofibrate but this was not 
significant statistically, A higher platelet count during clofibrate therapy 
has been demonstrated previously by Gilbert & Mustard (1963), O'Brien &
Haywood (1966) and Millac, Caspary & Prineas (1967). Since there does 
not appear to be any change in plasma volume or total body water during 
treatment with clofibrate (MacMillan, Oliver, Simpson & Tothill 1965) the 
increase in platelet count is likely to be a real one. This rise has been 
attributed to reduced adhesiveness associated with increased platelet 
survival and reduced turnover (Gilbert & Mustard 1963). In the present 
instance and also in the cases of O'Brien & Heywood (1966) and Millac, Caspary 
& Prineas (1967) however, there was no decrease in platelet adhesiveness.
The explanation of the rise in platelet count therefore remains obscure.
It is difficult to compare the results obtained by different workers 
into the effects of clofibrate on platelet adhesiveness because of the 
many variables. All the references quoted so far have used the Payling 
Wright method except Gilbert & Mustard (1963). Some workers have used 
clofibrate alone (Atromid S) others clofibrate with androsterone (Atromid); 
the states of the patients with regard to fasting and preceding exercise 
is difficult to assess and is probably varied; the doses of the drug given 
and the ti ling of the investigation in relation to the commencement of therapy 
are also variables. The dose used in the present investigation was low and 
the measurements of adhesiveness were carried out within a month of 
commencing therapy. Nevertheless, lipid changes resulting from the drug 
therapy were apparent and yet there was no alteration in platelet adhesiveness. 
There is no apparent explanation to account for the fact that some workers 
have found lowering of platelet adhesiveness while others have not. Lowering 
of platelet adhesiveness has been found with "Atromid" (clofibrate with 
androsterone)(Carson et al. 1963; Symonds et al. 1964, Carson et al, 1966) 
and with "Atromid-S" (clofibrate alone) (Symonds et al. 1964, Carson et al, 
1966).
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No change in platelet adhesiveness has been found with "Atromid" by Millac 
et al. (1967) and with Atromid-S by O'Brien and Heyii-zood (1966). The 
androsterone cannot therefore account for the discrepancy. The results of 
the present study agree most closely with O'Brien & Heywood (1966) who 
found an increase in platelet count with no change in platelet adhesiveness. 
These workers also commented on the variability of platelet adhesiveness for 
any one subject from day to day, a factor which can be seen in this study 
also.
Significant depression of the serum triglyceride occurred within 2 weeks 
of commencing clofibrate. The fall was seen in all subjects except one.
Serum cholesterol levels also fell in 5 out of 6 instances but in this case 
the fall failed to be statistically significant (the subject whose cholesterol 
did not alter was not the same as that whose triglyceride did not fall).
That IG of clofibrate can produce lipid changes within 2 weeks was 
established by the investigation involving 11 subjects carried out by Mitchell 
and Murchison (unpublished) in this department. This rapid onset had 
previously been observed by Carlson, Hogstedt, & Oro (1963) and Denborough, 
Lovell & Trevaks (1963) using a combination of clofibrate and androsterone 
("Atromid"),
The significant finding of elevation of plasma NEFA levels during 
clofibrate therapy is at variance with the literature on the subject.
Several workers (MacMillan, Oliver, Simpson & Tothill 1965 and Rifkind 
1966) have shown that when the plasma clofibrate level is taken into account, 
there is significant depression of plasma NEFA levels. The present study 
was carried out at a much earlier stage during clofibrate therapy and it 
would appear likely that the rise in plasma NEFA level is due to the addition 
of clofibrate (which is extracted along with plasma NEFA by the Dole method) 
prior to the production of its lowering effect on plasma NEFA levels.
Summary
Clofibrate in a dose which was sufficient to lower serum cholesterol and 
triglyceride levels and also to raise plasma NEFA levels, did not alter
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platelet adhesiveness. Platelet adhesiveness does not therefore appear to 
be affectedly the addition of fatty acid-like materials such as clofibrate 
and Iflinolenic acid nor by changes in serum cholesterol, serum triglyceride 
or plasma NEFA produced by these substances.
SECTION IV
REVIEW OF THESIS WITH CONCLUSIONS
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Review and Conclusions of Thesis
The aim of this thesis was to explore the possibility of a link between 
the lipid and thrombogenic theories of atheroma production. The most likely 
site of this link appeared to be the blood platelet because of the large 
volume of evidence associating platelets and fatty acids in vitro. The 
bulk of this thesis has been an investigation to determine if this link 
is present in vivo. Platelet adhesiveness was chosen as the measure of 
platelet function because it had been shown by several workers to be elevated 
in ischaemic heart disease and because the published evidence linking fatty 
acids and platelets had incriminated the ADP mechanism, red cell integrity 
and the early surface active sUages of coagulation. Platelet adhesiveness 
would be expected to be an indicator of acceleration of any of these 
components and therefore a good measure of the existence of such a link.
The measurement of platelet adhesiveness by the Payling Wright method 
is technically very simple and its accuracy depends on platelet counting.
The method described for platelet counting using ammonium oxalate to lyse 
the red cells and also phase contrast microscopy, proved to be satisfactory. 
The accuracy of the method was shown to be comparable to that of other 
workers. The platelet count although steady under basal conditions is 
influenced by very simple things such as exercise or smoking a cigarette.
Drugs too have been shown to alter it. Noradrenaline causes an increase 
while stimulation of beta-adrenergic receptors with isoprenaline surprisingly 
causes quite a marked decrease. Over the longer term, clofibrate appears to 
produce an increase in the platelet count. The platelet count for any 
individual varies randomly from day to day. This variation corresponds 
well to tint described in the literature. For example, in the 
investigations into the effect of clofibrate and Calmic 131A (12 subjects; 
average of 8 counts each) the average difference between the highest and 
lowest platelet counts for each subject was 43,000/ cu.mm. This is comparable 
to 30,300/ cu.mm. (4 subjects; 4 counts each) obtained from the data of Sloan 
(1951). Over a longer period such as that involved in the sucrose study, the 
figures were again comparable. The average difference between the highest
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and lowest counts for each subject in this study was 96,400/mm (approx.20 
counts) compared to 106,400/mm (32 counts) from the data of Brecher, 
Schneiderman & Gronkite (1953). Thus the longer an investigation continues, 
the greater will be the variation in platelet count for any individual.
This is due to the fact that the number of counts and therefore the chance 
of errors arising due to inaccuracies in. counting are increasing. However, 
in addition to the errors in platelet counting, other variables will be 
contributing, such as the state of hydration (as shown by the fasting 
experiment), exercise or smoking.
Platelet adhesiveness has been shown to be stable under basal conditions 
over short periods of time but like the platelet count it is affected by many 
commonly occurring stimuli. Minor stress in the form of embarrassment 
(puffing an unlit cigarette) appears to produce an effect. Stress of 
greater intensity such as a surgical operation or the infusion of 
noradrenaline also produces an increase in adhesiveness. Exercise and 
the ingestion of fat or glucose are also followed by increased platelet 
adhesiveness. The conditions under which platelet adhesiveness is measured 
should therefore be strictly controlled. Subjects should be at rest for at 
least half an hour and should be fasting. A point which seems to have been 
overlooked by other workers using the Payling Wright method is that the 
interval between venepuncture and the commencement of the measurement 
should be controlled. In the present series of experiments this variable 
accounts for the differences in mean basal platelet adhesiveness between 
some experiments. The measurement was carried out 5 minutes after venepuncture 
in the studies into the effect of smoking, noradrenaline and isoprenaline, 
glucose, sucrose, Calmic 131A and clofibrate. The investigations into the 
effects of surgery, starvation and fat on the other hand were carried out 20
minutes after venepuncture while that on exercise was carried out 3 minutes
after venepuncture. ■ The reason for these different intervals was that in 
the 20mLnute cases, delays were expected with some samples due to patients 
being in other wards of the hospital, while in the exercise experiment 3 
minutes was chosen to fit into the design of the experiment in order that
all the different manoeuvres might be performed.
Adhesiveness levels are therefore only comparable in the experiments in
100
which the interval between venepuncture and measurement is the same. Due to 
a lack of numbers, platelet adhesiveness in subjects with ischaemic heart 
disease was not statistically higher than the others. If however, the subjects 
with ischaemic heart disease from the other experiments in which the time 
between venepuncture and measurement was 5 minutes are added in to the results 
already quoted, the difference becomes statistically significant (Table XXVIII. 
Fig 15.).
Figure 15.
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TABLE XX\a.II Mean platelet adhesiveness for all subjects with ischaemic 
heart disease included in'the thesis compared to that of 
the subjects without clinical evidence of ischaemic heart 
disease from Figure 3.
ischaemic heart 
disease
others
number of subjects 28 26
males/females 23/5 12/14
average age 56.7 years 44.2 years
platelet adhesiveness 36.1% 29.5%
+  p<^0.02
TABLE XXIX Comparison of platelet adhesiveness (measured 5 minutes after 
venepuncture) in all subjects with ischaemic heart disease 
with those without clinical evidence of ischaemic heart 
disease.
ischaemic heart 
disease others
number of subjects 28 55
*
platelet adhesiveness 36.1% 31.2%
<(0.05.
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The two groups it should be emphasised, are not age and sex matched, the 
ischaemic heart disease group containing 23 males and 5 females with an 
average age of 44.2 years. As pointed out already however there didnot 
appear to be any difference in adhesiveness between the sexes or any 
increase with age. The difference in platelet adhesiveness is also 
significant if the subjects without ischaemic heart disease in the comparable 
experiments are added to the "control" group. This merely increases the 
size of this group and makes the "control" group twice as large as the other 
(Table XXIX).
In the conditions investigated which predispose to ischaemic heart 
disease, there was no evidence of increased platelet adhesiveness. Obese 
subjects did not have increased adhesiveness and weight loss did not result 
in any significant change in adhesiveness. There was no acute change in 
adhesiveness following cigarette smoking. The effect of chronic cigarette 
smoking cannot be assessed from the experiments carried out but it is 
interesting that the mean basal levels in the subjects involved in the 
study (all smoked at least 10 cigarettes/day) were slightly higher on 
average than in any other comparable experiment. Adhesiveness in subjects 
with hypercholesterolaemia or hypertriglyceridaemia was not formally 
investigated but it can be said that when the serum cholesterol or serum 
triglyceride was significantly altered there were no corresponding changes 
in platelet adhesiveness nor was there any relationship between the levels 
of cholesterol or triglyceride and platelet adhesiveness. Sucrose has been 
put forward as an aetiological factor in ischaemic heart disease but here 
again, taking the results over all, there did not appear to be any increase 
in platelet adhesiveness over a period of 1 month on a sucrose diet.
There are considerable difficulties attached to investigating platelet 
adhesiveness changes over a prolonged period of time. The variation in 
platelet adhesiveness is much greater than that obtained for duplicates 
and during short term experiments even when great care is taken to standardise 
the conditions under which the blood samples are obtained. This variation 
means that very large changes in platelet adhesiveness would have to occur 
in response to specific stimuli in order to be statistically significant.
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Most workers tend to hide individual results by presenting averages and so it 
is difficult to assess the variation found by others. O'Brien & Heywood 
(1966) stated that the variation was considerable but did not quote figures. 
Symons, de Toszeghi & Cook (1964) in their investigation in the effect of 
clofibrate show all their results. Spontaneous variations of up to 23% 
adhesiveness in one subject are apparent during the control period. Besterman 
et al. (1967) shows graphs of results in 4 subjects over a period of months 
and the variation here again is 25%.adhesiveness in one of the subjects.
This represents around a quarter of the total adhesiveness scale and when 
one realises that in practice most platelet adhesiveness results occur within 
a limited range of about 40% of the total scale the practicability of 
undertaking any long term study involving platelet adhesiveness must be 
seriously questioned.
The present series of investigations have been unsuccessful in establishing 
a definite link between platelets and fatty acids in vivo. A great many 
stimuli have been found to raise both platelet adhesiveness and plasma NEFA. 
These include surgery, noradrenaline infusion and also sham smoking. There 
was no correlation between the fatty acid and platelet changes except in 
the sham smoking/smoking experiments. Platelet adhesiveness has also been 
shown to rise following stimuli which lower plasma NEFA (glucose and exercise) 
and which do not alter plasma NEFA significantly (isoprenaline). In addition 
platelet adhesiveness was unchanged following fasting when the plasma NEFA 
levels were substantially elevated. It is clear that a rise in platelet 
adhesiveness can be associated with plasma NEFA changes going in either 
direction or indeed remaining relatively unchanged while platelet adhesiveness 
can be unchanged in spite of a rise in plasma NEFA. Thus there is no apparent 
association between changes in platelet adhesiveness and plasma NEFA or if 
there is, other more powerful influences have hidden the association.This is 
in agreement with Bridges, Dalby, Hadden, Johnston & Weaver (1967) who studied 
the effects of growth hormone and nicotinic acid on platelet adhesiveness and 
NEFA. The positive correlation demonstrated in the smoking and sham smoking 
experiments is unlikely therefore to be valid in view of the failure to 
demonstrate it in other situations.
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One might argue that the effects of fatty acids on platelets might not 
become apparent until all the tight binding sites for fatty acids on albumin 
had been saturated (i.e. at about 1212 . ) the reason being that only at
above this level would fatty acids be free to adhere to cell walls. This level 
was exceeded in the fasting experiment in 8 out of 16 subjects and yet no 
effect on the platelet count or platelet adhesiveness was noticed. It must 
be conceded that the levels of fatty acids were being overestimated due to the 
extraction of ketone bodies along with the fatty acids in this experiment. Howeve 
in the 8 instances, in which the fatty acids were doubly extracted, the level 
of 1212 ^ Eq/l, was exceeded twice without any effect on platelets or clinical 
evidence of thrombosis.
Since fatty acid transport is so rapid it, would not be unreasonable to 
expect the second class binding sites on albumin and on cell walls to be 
important in fatty acid transport. After all, how could fatty acids be 
rapidly removed from tight binding sites on albumin and into cells without 
involving the second class binding sites on the cell wall? The plasma NEFA 
level in fact does not indicate the rate of turnover of fatty acids, merely 
the balance between formation and removal. Could it be then that platelet 
adhesiveness changes might be related to the rate of turnover of fatty acids 
through binding sites on cell walls? There is evidence against this.
Platelet adhesiveness was increased when plasma NEFA levels were reduced due 
to reduction in turnover following oral glucose administration and also due 
to increase in turnover following exercise.
In view of the in vitro evidence suggesting that unsaturated fatty acids 
may protect platelets from the effects of saturated acids, it could be 
argued that the proportion of unsaturated to saturated fatty acids is the 
factor determining platelet adhesiveness. Here again, the evidence from the 
sham smoking experiment makes this unlikely since an increase in the proportion 
of unsaturated fatty acids was accompanied by an increase in platelet 
adhesiveness. Also the administration of unsaturated fatty acids in Calmic 
131A in a dose sufficient to lower serum cholesterol did not significantly 
affect platelet adhesiveness, Clofibrate which has structural similarity to a fatt
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acid did not affect platelet adhesiveness when given in a dose sufficient 
to alter serum lipid levels. Thus, investigations launched from different 
fronts, have failed to reveal any relationship between plasma NEFA and 
platelet adhesiveness in vivo. The link between fatty acids and platelets 
postulated in previous in vitro studies cannot be substantiated by the present 
in vivo experiments. All the in vitro fatty acid preparations, however 
ingeneously they have been compounded, are completely unphysiological and 
therefore do not appear to have any "in vivo" significance.
It has been suggested that blood glucose may play some part in determining 
platelet adhesiveness, thus explaining why increased adhesiveness has been 
found in diabetics (Bridges, Dalby, Millar & Weaver, 1965). The increase in 
adhesiveness following oral glucose has been confirmed but there was no 
correlation between the changes. A rise in blood glucose following noradrenaline, 
isoprenaline and oral fat was accompanied by a rise in adhesiveness also, but 
again there was no correlation between the two changes. Exercise on the other 
hand caused an increase in platelet adhesiveness even though the blood sugar 
did not alter while the subjects with the most marked rises in blood sugar 
following cigarette smoking showed decreases in platelet adhesiveness. A fourth 
combination, namely a significant fall in blood sugar with no change in 
platelet adhesiveness, was found in the fasting experiment and this makes any 
correlation between blood sugar and platelet adhesiveness changes very unlikely. 
One might suggest that both plasma NEFA and blood sugar might be affecting 
platelet adhesiveness but this does not bear critical examination since a rise 
in both have been associated with both an increase (noradrenaline infusion) and 
a decrease (Smoking experiment) in platelet adhesiveness.
Therefore, no evidence has been found to link platelet adhesiveness with 
levels or changes in plasma NEFA, blood glucose, serum cholesterol or serum 
triglyceride in vivo. What does control platelet adhesiveness? Circulatory 
changes appear unlikely because a rise in adhesiveness was accompanied by a 
bradycardia in the noradrenaline experiment and by a tachycardia in the 
isoprenaline and exercise experiments while the blood pressure rose in 
the noradrenaline experiment but was unaffected in the isoprenaline experiment.
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Catecholamines 5 in view of the fact that adrenaline and noradrenaline can 
cause platelet aggregation in vitro, might be held responsible in these 
experiments for the increase in adhesiveness. Catecholamine release probably 
occurred in many of the other situations in which a rise in adhesiveness 
occurred, for example in the sham smoking and exercise studies. However there 
has never been any suggestion of catecholamine release following the ingestion 
of fat or glucose. Catecholamines might be expected to be released as a 
result of the stress of venepuncture. The pattern of change in platelet 
adhesiveness in the experiments does not support this idea since one would 
expect changes to have occurred during the basal periods if this was a 
significant factor and this did not occur.
As platelet adhesiveness is such a labile property it would appear likely 
that no one factor controls it. Like ischaemic heart disease, it probably 
has a multifactorial control mechanism although as demonstrated in this 
thesis the factors are likely to be difference from those causing ischaemic 
heart disease.
No relationship has been found between serum lipids and platelet 
adhesiveness. It has therefore not proved possible to link the thrombogenic 
and lipid theories of atheroma production via platelet adhesiveness. The 
role of the increased platelet adhesiveness found in ischaemic heart disease 
remains in doubt but it remains a cornerstone of the evidence supporting 
the thrombogenic theory.
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